<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">60326</article-id><article-id pub-id-type="doi">10.7554/eLife.60326</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-195795"><name><surname>Singh</surname><given-names>Amanjot</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9793-0404</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-195796"><name><surname>Hulsmeier</surname><given-names>Joern</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9209-5251</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195798"><name><surname>Kandi</surname><given-names>Arvind Reddy</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195799"><name><surname>Pothapragada</surname><given-names>Sai Shruti</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195797"><name><surname>Hillebrand</surname><given-names>Jens</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195800"><name><surname>Petrauskas</surname><given-names>Arnas</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9048-582X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195801"><name><surname>Agrawal</surname><given-names>Khushboo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9159-8615</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195802"><name><surname>RT</surname><given-names>Krishnan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195803"><name><surname>Thiagarajan</surname><given-names>Devasena</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-224595"><name><surname>Jayaprakashappa</surname><given-names>Deepa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-1027"><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4705-5629</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1169"><name><surname>Ramaswami</surname><given-names>Mani</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7631-0468</contrib-id><email>ramaswam@tcd.ie</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-195794"><name><surname>Bakthavachalu</surname><given-names>Baskar</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5114-3429</contrib-id><email>baskarb1@gmail.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>National Centre for Biological Sciences</institution><addr-line><named-content content-type="city">Bangalore</named-content></addr-line><country>India</country></aff><aff id="aff2"><label>2</label><institution>Trinity College Institute of Neuroscience, School of Genetics and Microbiology, Smurfit Institute of Genetics and School of Natural Sciences, Trinity College Dublin</institution><addr-line><named-content content-type="city">Dublin</named-content></addr-line><country>Ireland</country></aff><aff id="aff3"><label>3</label><institution>Tata Institute for Genetics and Society Centre at inStem, Bellary Road</institution><addr-line><named-content content-type="city">Bangalore</named-content></addr-line><country>India</country></aff><aff id="aff4"><label>4</label><institution>School of Biotechnology, Amrita Vishwa Vidyapeetham University</institution><addr-line><named-content content-type="city">Kollam</named-content></addr-line><country>India</country></aff><aff id="aff5"><label>5</label><institution>School of Basic Sciences, Indian Institute of Technology</institution><addr-line><named-content content-type="city">Mandi</named-content></addr-line><country>India</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Black</surname><given-names>Douglas L</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Los Angeles</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Banerjee</surname><given-names>Utpal</given-names></name><role>Senior Editor</role><aff><institution>University of California, Los Angeles</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>10</day><month>03</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e60326</elocation-id><history><date date-type="received" iso-8601-date="2020-06-23"><day>23</day><month>06</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-02-23"><day>23</day><month>02</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Singh et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Singh et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-60326-v1.pdf"/><abstract><p>Ataxin-2 (Atx2) is a translational control molecule mutated in spinocerebellar ataxia type II and amyotrophic lateral sclerosis. While intrinsically disordered domains (IDRs) of Atx2 facilitate mRNP condensation into granules, how IDRs work with structured domains to enable positive and negative regulation of target mRNAs remains unclear. Using the Targets of RNA-Binding Proteins Identified by Editing technology, we identified an extensive data set of Atx2-target mRNAs in the <italic>Drosophila</italic> brain and S2 cells. Atx2 interactions with AU-rich elements in 3′UTRs appear to modulate stability/turnover of a large fraction of these target mRNAs. Further genomic and cell biological analyses of Atx2 domain deletions demonstrate that Atx2 (1) interacts closely with target mRNAs within mRNP granules, (2) contains distinct protein domains that drive or oppose RNP-granule assembly, and (3) has additional essential roles outside of mRNP granules. These findings increase the understanding of neuronal translational control mechanisms and inform strategies for Atx2-based interventions under development for neurodegenerative disease.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Ataxin-2</kwd><kwd>TRIBE</kwd><kwd>mRNA</kwd><kwd>translational control</kwd><kwd>rnp granule</kwd><kwd>neurodegeneration</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001602</institution-id><institution>Science Foundation Ireland</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ramaswami</surname><given-names>Mani</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005879</institution-id><institution>National Centre for Biological Sciences</institution></institution-wrap></funding-source><award-id>NCBS-TIFR Core funding</award-id><principal-award-recipient><name><surname>VijayRaghavan</surname><given-names>K</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001843</institution-id><institution>Science and Engineering Research Board</institution></institution-wrap></funding-source><award-id>SB/YS/LS-194/2014</award-id><principal-award-recipient><name><surname>Bakthavachalu</surname><given-names>Baskar</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008605</institution-id><institution>Indian National Science Academy</institution></institution-wrap></funding-source><award-id>INSA/SP/YSP/143/2017</award-id><principal-award-recipient><name><surname>Singh</surname><given-names>Amanjot</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001843</institution-id><institution>Science and Engineering Research Board</institution></institution-wrap></funding-source><award-id>Vajra award</award-id><principal-award-recipient><name><surname>Ramaswami</surname><given-names>Mani</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001409</institution-id><institution>Department of Science and Technology, Ministry of Science and Technology</institution></institution-wrap></funding-source><award-id>INSPIRE Fellowship</award-id><principal-award-recipient><name><surname>Agrawal</surname><given-names>Khushboo</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009053</institution-id><institution>Wellcome Trust/DBT India Alliance</institution></institution-wrap></funding-source><award-id>IA/1/19/1/504286</award-id><principal-award-recipient><name><surname>Bakthavachalu</surname><given-names>Baskar</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Ataxin-2 interacts with neuronal mRNA in RNP granules.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Ataxin-2’s involvement in human disease, its relevance for therapeutics development, and its established roles in ribonucleoprotein (RNP)-phase transitions, cell physiology, metabolic control, and animal behavior have led to considerable interest in understanding molecular mechanisms by which the protein functions. At a molecular level, Ataxin-2 positively or negatively regulates the translation of specific mRNAs (<xref ref-type="bibr" rid="bib39">Lee et al., 2017</xref>; <xref ref-type="bibr" rid="bib42">Lim and Allada, 2013</xref>; <xref ref-type="bibr" rid="bib46">McCann et al., 2011</xref>; <xref ref-type="bibr" rid="bib89">Zhang et al., 2013</xref>). At the same time, the protein mediates the assembly of mRNPs into cytoplasmic mRNP granules visible in resting neurons or in RNA stress granules (SGs) that occur in most cells in response to stress (<xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref>; <xref ref-type="bibr" rid="bib9">Bentmann et al., 2013</xref>). At a cellular level, Ataxin-2 contributes to cell viability and differentiation as well as cellular responses to viral, ER, heat-, and oxidative stress (<xref ref-type="bibr" rid="bib11">Bonenfant et al., 2019</xref>; <xref ref-type="bibr" rid="bib19">Del Castillo et al., 2019</xref>; <xref ref-type="bibr" rid="bib60">Ralser et al., 2005</xref>; <xref ref-type="bibr" rid="bib74">van de Loo et al., 2009</xref>). Finally, at an organismal level, the protein regulates metabolism, circadian rhythm, and the consolidation of long-term memory (<xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">Lim and Allada, 2013</xref>; <xref ref-type="bibr" rid="bib49">Meierhofer et al., 2016</xref>; <xref ref-type="bibr" rid="bib57">Pfeffer et al., 2017</xref>; <xref ref-type="bibr" rid="bib89">Zhang et al., 2013</xref>). Parallel clinical genetic studies have shown that genetic mutations in human Ataxin-2 (Atxn2) can cause the hereditary neurodegenerative diseases spinocerebellar ataxia type II or amyotrophic lateral sclerosis (ALS) (<xref ref-type="bibr" rid="bib18">Daoud et al., 2011</xref>; <xref ref-type="bibr" rid="bib21">Elden et al., 2010</xref>; <xref ref-type="bibr" rid="bib34">Lastres-Becker et al., 2008</xref>; <xref ref-type="bibr" rid="bib38">Lee et al., 2011</xref>; <xref ref-type="bibr" rid="bib67">Scoles and Pulst, 2018</xref>; <xref ref-type="bibr" rid="bib79">Wadia, 1977</xref>; <xref ref-type="bibr" rid="bib80">Wadia and Swami, 1971</xref>), and subsequent work showing that genetic reduction of Ataxin-2 activity slows neurodegeneration in animal models of ALS has inspired the design and development of therapeutics targeting human Ataxin-2 (<xref ref-type="bibr" rid="bib7">Becker et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Becker and Gitler, 2018</xref>; <xref ref-type="bibr" rid="bib21">Elden et al., 2010</xref>; <xref ref-type="bibr" rid="bib66">Scoles et al., 2017</xref>).</p><p>The above biological and clinical studies of Ataxin-2 are connected by the insight that intrinsically disordered domains (IDRs) present on RNA-binding proteins contribute to macromolecular condensation or liquid–liquid phase separation reactions, wherein monomeric units form dynamic assemblies held together by weak multivalent interactions (<xref ref-type="bibr" rid="bib28">Jain and Vale, 2017</xref>; <xref ref-type="bibr" rid="bib32">Kato and McKnight, 2018</xref>; <xref ref-type="bibr" rid="bib51">Murray et al., 2017</xref>; <xref ref-type="bibr" rid="bib62">Saha and Hyman, 2017</xref>; <xref ref-type="bibr" rid="bib76">Van Treeck et al., 2018</xref>; <xref ref-type="bibr" rid="bib77">Van Treeck and Parker, 2018</xref>). Significantly, IDRs not only support assembly of mRNP granules but also are prone to assemble into amyloid-like fibers. Disease-causing mutations often increase the efficiency of amyloid formation, particularly within mRNP granules where the RNA-binding proteins are concentrated (<xref ref-type="bibr" rid="bib15">Courchaine et al., 2016</xref>; <xref ref-type="bibr" rid="bib30">Kato et al., 2012</xref>; <xref ref-type="bibr" rid="bib42">Lim and Allada, 2013</xref>; <xref ref-type="bibr" rid="bib52">Nedelsky and Taylor, 2019</xref>; <xref ref-type="bibr" rid="bib55">Patel et al., 2015</xref>; <xref ref-type="bibr" rid="bib61">Ramaswami et al., 2013</xref>; <xref ref-type="bibr" rid="bib85">Xiang et al., 2015</xref>; <xref ref-type="bibr" rid="bib87">Yang et al., 2019</xref>). The broad proposal that SGs serve as ‘crucibles’ for the initiation of neurodegenerative disease (<xref ref-type="bibr" rid="bib41">Li et al., 2013</xref>; <xref ref-type="bibr" rid="bib61">Ramaswami et al., 2013</xref>; <xref ref-type="bibr" rid="bib84">Wolozin and Ivanov, 2019</xref>) explains why SG proteins are often mutated in familial ALS or frontotemporal dementia (FTD) and why these proteins are observed in intracellular inclusions typical of ALS/FTD (<xref ref-type="bibr" rid="bib4">Arai et al., 1992</xref>; <xref ref-type="bibr" rid="bib12">Brettschneider et al., 2015</xref>; <xref ref-type="bibr" rid="bib37">Lee et al., 1991</xref>).</p><p>The domain structure of Ataxin-2 is highly conserved across species, with N-terminal Like-Sm (Lsm) and Lsm-associated (LsmAD) domains, a more carboxy-terminal polyA binding protein interaction motif 2 (PAM2) domain, as well as strongly disordered regions (respectively mIDR and cIDR) in the middle and C-terminal regions of the protein (<xref ref-type="bibr" rid="bib2">Albrecht et al., 2004</xref>, <xref ref-type="bibr" rid="bib64">Satterfield and Pallanck, 2006</xref>; <xref ref-type="bibr" rid="bib53">Nonhoff et al., 2007</xref>; <xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref>). Genetic studies in <italic>Drosophila</italic>, which has a single gene for Ataxin-2 as against two <italic>atxn2</italic> and <italic>atxn2-like</italic> in mammals, indicate that different Atx2 domains encode distinct, biological functions. Specifically, while each structured domain is essential for normal viability, the IDR domains are not. However, the cIDR is required for normal mRNP assembly and long-term memory as well as for facilitating cytotoxicity in <italic>Drosophila</italic> Fus and C9orf72 models for ALS/FTD (<xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref>). These observations, while instructive in terms of functions of the Atx2-IDR and mRNP granules, provide no direct insight into other functions and mechanisms mediated by structured domains of Atx2 or their roles in biology.</p><p>To better understand the broad roles and mechanisms of Atx2, we used the Targets of RNA-Binding Proteins Identified by Editing (TRIBE) technology (<xref ref-type="bibr" rid="bib10">Biswas et al., 2020</xref>; <xref ref-type="bibr" rid="bib47">McMahon et al., 2016</xref>) to globally identify Atx2-interacting mRNAs from <italic>Drosophila</italic> adult brain and study how these in vivo interactions were influenced by different domains of the protein. In addition to identifying biologically important targets of Atx2, the results described here offer unexpected information into the mechanisms of Atx2 protein function. Atx2 associates with mRNAs predominantly within mRNP granules, where it binds preferentially near AU-rich elements (AREs) in the 3′UTRs to stabilize the majority of the targets. While the cIDR enables mRNA interactions and granule assembly, the Lsm domain reduces both mRNP assembly and Atx2-target interactions. Taken together, our data (1) provide a rich data set of Atx2-target mRNAs, (2) point to a novel essential function of Atx2 outside of mRNP granules, and (3) indicate competing disassembly and pro-assembly activities within Atx2 encoded by the Lsm and IDR domains, respectively. In addition to being of specific biological interest, these conclusions are relevant to current therapeutic strategies based on targeting human Atxn2.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Using TRIBE to identify Atx2-target mRNAs in <italic>Drosophila</italic> brain</title><p>Atx2 is abundantly expressed in brain tissue. To identify in vivo targets of Atx2 in <italic>Drosophila melanogaster</italic> brain, we used TRIBE, a technology previously shown to reproducibly identify RNA binding protein (RBP) target mRNAs in vivo (<xref ref-type="bibr" rid="bib47">McMahon et al., 2016</xref>). We generated transgenic flies that express Atx2 linked to the catalytic domain of <italic>Drosophila</italic> RNA-modifying enzyme adenosine deaminase (ADARcd) at the carboxy terminal along with a V5 epitope tag under the control of the Gal4-responsive UAS promoter (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). In tissue expressing the Atx2-ADARcd transgene, mRNAs should undergo adenosine-to-inosine editing specifically at positions proximal to Atx2 binding sites (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). In an <italic>elav-Gal4</italic> background, where the Gal4 transcription factor is expressed in postmitotic neurons, Atx2-ADARcd is expressed specifically in the nervous system. We further temporally restricted neural expression to adult flies with the use of the temperature-sensitive Gal4 inhibitor, GAL80<sup>ts</sup>, that is active at temperatures below 18°C. Thus, in <italic>elav-Gal4; TubGal80<sup>ts</sup>, UAS-Atx2-ADARcd</italic> adult flies shifted from 18°C to 29°C for 5 days shortly after eclosion, and neural mRNAs expressed in adult flies would be susceptible to editing at adenosine residues proximal to Atx2 binding sites.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Using Targets of RNA-Binding Proteins Identified by Editing (TRIBE) to identify Atx2-interacting mRNAs in the adult fly brain.</title><p>(<bold>A</bold>) Schematic and flow chart for TRIBE analysis: the Atx2-ADARcd fusion protein is expressed in the adult fly brain, total brain mRNA isolated, sequenced, and analyzed using a published TRIBE pipeline. (<bold>B</bold>) Heatmaps show edit percentages of individual transcript coordinates. Replicate experiments R1 and R2 identify largely overlapping edit sites and edited mRNAs. The common targets (intersect between R1 and R2) show almost reproducible edit levels. The inset (heatmaps on either sides of the common intersected list) indicates that several mRNAs are identified as ‘non-replicates’ between R1 or R2 because they do not cross quality control thresholds (edit percentages or read counts) and not because of robust differences between replicates. (<bold>C</bold>) Bar plot showing the number of edits with a significant number of genes edited at a single site. (<bold>D</bold>) The mRNA edits are independent of expression levels. A scatter plot shows expression differences of all the mRNAs expressed in fly brain. Red dots represent the edited mRNAs while gray dots represent the mRNAs of the brain transcriptome that are not edited. (<bold>E</bold>) Sanger sequencing confirms editing site identified by TRIBE analysis. Data shown for one target mRNA (Akh). Red bars show the edit percentages at the different modified nucleotides with respect to the total Akh mRNA shown in gray. The black bar indicates identified edits that are below 15% threshold (see also <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>).</p><p> <supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Data related to <xref ref-type="fig" rid="fig1">Figure 1B</xref>.</title><p>Percentage edits for Atx2-target mRNAs in RNAseq replicates.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60326-fig1-data1-v1.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Data related to <xref ref-type="fig" rid="fig1">Figure 1C</xref>.</title><p>Atx2-target mRNAs along with the number of edits.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60326-fig1-data2-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title><italic>Atx2-ADARcd</italic> fusion protein constructs.</title><p>Schematic showing the Atx2-ADARcd construct.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>UAS-Atx2-ADARcd expression was driven using <italic>elav-Gal4;tub-Gal80<sup>ts</sup></italic> in adult fly brain for 5 days.</title><p>Brains dissected from flies maintained at 29℃ for 5 days were stained using anti-V5 (<bold>A, A'</bold>) and anti-Atx2 (<bold>B, B'</bold>) antibodies. (<bold>A-C'</bold>) Confocal images of Oblique frontal view of the <italic>Drosophila</italic> brain. (<bold>A,B,C</bold>) (dorsal is more anterior) of a complete. (<bold>A',B'C'</bold>) higher magnification of the respective overview images.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Unique mapping percentage for various RNAseq replicates.</title><p>Total RNA was isolated from 10 to 12 brains for each replicate. Poly(A)-enriched mRNA was sequenced using paired-end libraries on Illumina 2500. The reads obtained were of high quality, and mapping to <italic>Drosophila melanogaster</italic> genome was &gt;80% for all the samples.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig1-figsupp3-v1.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>An example of a gene, <italic>14-3-3 epsilon</italic>, showing multiple edits specifically in the exons.</title><p>Red lines show the edit percentages at the different modified nucleotides with respect to the total mRNA present at a given moment of time.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig1-figsupp4-v1.tif"/></fig></fig-group><p>To identify neural mRNA targets of Atx2, we isolated polyA-selected RNAs from Atx2-ADARcd expressing <italic>Drosophila</italic> brain and sequenced these using Illumina Hiseq 2500 and reads were subsequently analyzed according to <xref ref-type="bibr" rid="bib47">McMahon et al., 2016</xref> (with slight modifications, see Materials and methods) to identify sites and efficiency of Atx2-ADARcd-mediated mRNA editing (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Adult brain expression for Atx2-ADARcd was verified using antibody staining for V5 epitope (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Experiments were carried out in duplicates. The reads obtained were between 20 and 25 million per sample, were of high quality, and more than 80% of these mapped to specific <italic>Drosophila</italic> mRNAs (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>).</p><p>Transcripts corresponding to 8% of expressed genes showed adenosine edits. Of the 528 and 481 edit sites represented in independent replicates, at least 317 were common to both samples, demonstrating the reproducibility of the experiments (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). These 317 common edits could be assigned to 256 unique genes, with the majority of genes only being edited at a single site (215 genes, 67.8% of edits) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The Atx2-target mRNAs were distributed across the brain transcriptome irrespective of the abundance of an mRNA indicating that edits were not random events, but rather reflect sequence- and structure-specific association of these mRNAs with Atx2-ADARcd (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). We further validated the TRIBE analysis/Illumina Hiseq pipeline using Sanger sequencing for a few identified target mRNAs. For instance, Sanger sequencing confirmed that edits in <italic>Adipokinetic hormone</italic> (<italic>Akh</italic>) and <italic>14-3-3 epsilon</italic> mRNAs occur at identified sites, with efficiencies indicated by TRIBE analysis (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). Taken together, the data indicates that Atx2 associates with specific RNA motifs present on targets identified by TRIBE analyses from fly brain.</p><p>A Gene Ontology analysis of Atx2 targets (<xref ref-type="table" rid="table1">Table 1</xref>) indicated particular enrichment of mRNAs encoding neuropeptides and hormones, as well as mRNAs encoding monoamine transporters, ion channels, and vesicle transport proteins. This is broadly consistent with and suggests the mechanisms by which Atx2 functions in translational control of physiological and neural circuit plasticity.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Gene Ontology (GO) analysis of Atx2 brain targets.</title><p>GO analysis using PANTHER shows a large enrichment of neuronal mRNAs coding for neuropeptides and proteins involved in neuronal signaling pathways. FDR: false discovery rate.</p><p> <supplementary-material id="table1sdata1"><label>Table 1—source data 1.</label><caption><title>Gene Ontology (GO) terms for Atx2 brain targets.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60326-table1-data1-v1.xlsx"/></supplementary-material> </p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Molecular function</th><th valign="bottom">Fold enrichment</th><th valign="bottom">Probability (FDR)</th><th valign="bottom">Targets (%)</th><th valign="bottom">Genome (%)</th><th valign="bottom">GO term</th></tr></thead><tbody><tr><td valign="bottom">Signaling receptor binding</td><td valign="bottom">7.75</td><td valign="bottom">4.47E-11</td><td valign="bottom">14.46</td><td valign="bottom">1.87</td><td valign="bottom">GO:0005102</td></tr><tr><td valign="bottom">Neuropeptide hormone activity</td><td valign="bottom">27.67</td><td valign="bottom">2.52E-09</td><td valign="bottom">6.63</td><td valign="bottom">0.24</td><td valign="bottom">GO:0005184</td></tr><tr><td valign="bottom">Hormone activity</td><td valign="bottom">18.64</td><td valign="bottom">5.74E-08</td><td valign="bottom">6.63</td><td valign="bottom">0.36</td><td valign="bottom">GO:0005179</td></tr><tr><td valign="bottom">Neuropeptide receptor binding</td><td valign="bottom">38.74</td><td valign="bottom">2.08E-06</td><td valign="bottom">4.22</td><td valign="bottom">0.11</td><td valign="bottom">GO:0071855</td></tr><tr><td valign="bottom">G protein-coupled receptor binding</td><td valign="bottom">13.84</td><td valign="bottom">3.79E-06</td><td valign="bottom">6.03</td><td valign="bottom">0.44</td><td valign="bottom">GO:0001664</td></tr><tr><td valign="bottom">Receptor regulator activity</td><td valign="bottom">9.58</td><td valign="bottom">4.55E-06</td><td valign="bottom">7.23</td><td valign="bottom">0.76</td><td valign="bottom">GO:0030545</td></tr><tr><td valign="bottom">Receptor ligand activity</td><td valign="bottom">9.41</td><td valign="bottom">1.96E-05</td><td valign="bottom">6.63</td><td valign="bottom">0.71</td><td valign="bottom">GO:0048018</td></tr><tr><td valign="bottom">Signaling receptor activator activity</td><td valign="bottom">9.04</td><td valign="bottom">2.58E-05</td><td valign="bottom">6.63</td><td valign="bottom">0.74</td><td valign="bottom">GO:0030546</td></tr><tr><td valign="bottom">Organic hydroxy compound transmembrane transporter activity</td><td valign="bottom">83.02</td><td valign="bottom">3.38E-04</td><td valign="bottom">2.41</td><td valign="bottom">0.03</td><td valign="bottom">GO:1901618</td></tr><tr><td valign="bottom">Monoamine transmembrane transporter activity</td><td valign="bottom">66.41</td><td valign="bottom">5.52E-04</td><td valign="bottom">2.41</td><td valign="bottom">0.04</td><td valign="bottom">GO:0008504</td></tr><tr><td valign="bottom">Phosphoric ester hydrolase activity</td><td valign="bottom">4.93</td><td valign="bottom">6.43E-04</td><td valign="bottom">7.84</td><td valign="bottom">1.59</td><td valign="bottom">GO:0042578</td></tr><tr><td valign="bottom">Anion:sodium symporter activity</td><td valign="bottom">55.35</td><td valign="bottom">6.44E-04</td><td valign="bottom">2.41</td><td valign="bottom">0.05</td><td valign="bottom">GO:0015373</td></tr><tr><td valign="bottom">Sodium:chloride symporter activity</td><td valign="bottom">55.35</td><td valign="bottom">6.84E-04</td><td valign="bottom">2.41</td><td valign="bottom">0.05</td><td valign="bottom">GO:0015378</td></tr><tr><td valign="bottom">Phosphoprotein phosphatase activity</td><td valign="bottom">7.95</td><td valign="bottom">7.06E-04</td><td valign="bottom">5.43</td><td valign="bottom">0.69</td><td valign="bottom">GO:0004721</td></tr><tr><td valign="bottom">Anion:cation symporter activity</td><td valign="bottom">36.9</td><td valign="bottom">1.81E-03</td><td valign="bottom">2.41</td><td valign="bottom">0.07</td><td valign="bottom">GO:0015296</td></tr><tr><td valign="bottom">Cation:chloride symporter activity</td><td valign="bottom">36.9</td><td valign="bottom">1.91E-03</td><td valign="bottom">2.41</td><td valign="bottom">0.07</td><td valign="bottom">GO:0015377</td></tr><tr><td valign="bottom">Phosphatase activity</td><td valign="bottom">5.05</td><td valign="bottom">2.53E-03</td><td valign="bottom">6.63</td><td valign="bottom">1.32</td><td valign="bottom">GO:0016791</td></tr><tr><td valign="bottom">Serotonin:sodium symporter activity</td><td valign="bottom">83.02</td><td valign="bottom">4.17E-03</td><td valign="bottom">1.81</td><td valign="bottom">0.03</td><td valign="bottom">GO:0005335</td></tr><tr><td valign="bottom">Neurotransmitter:sodium symporter activity</td><td valign="bottom">14.82</td><td valign="bottom">5.04E-03</td><td valign="bottom">3.02</td><td valign="bottom">0.21</td><td valign="bottom">GO:0005328</td></tr><tr><td valign="bottom">Protein tyrosine/serine/threonine phosphatase activity</td><td valign="bottom">23.72</td><td valign="bottom">6.17E-03</td><td valign="bottom">2.41</td><td valign="bottom">0.11</td><td valign="bottom">GO:0008138</td></tr><tr><td valign="bottom">Solute:sodium symporter activity</td><td valign="bottom">11.53</td><td valign="bottom">1.26E-02</td><td valign="bottom">3.02</td><td valign="bottom">0.27</td><td valign="bottom">GO:0015370</td></tr><tr><td valign="bottom">mRNA 3'UTR binding</td><td valign="bottom">11.22</td><td valign="bottom">1.36E-02</td><td valign="bottom">3.02</td><td valign="bottom">0.27</td><td valign="bottom">GO:0003730</td></tr><tr><td valign="bottom">Protein tyrosine phosphatase activity</td><td valign="bottom">10.64</td><td valign="bottom">1.59E-02</td><td valign="bottom">3.02</td><td valign="bottom">0.29</td><td valign="bottom">GO:0004725</td></tr><tr><td valign="bottom">Neurotransmitter transmembrane transporter activity</td><td valign="bottom">10.64</td><td valign="bottom">1.65E-02</td><td valign="bottom">3.02</td><td valign="bottom">0.29</td><td valign="bottom">GO:0005326</td></tr><tr><td valign="bottom">Adrenergic receptor activity</td><td valign="bottom">24.91</td><td valign="bottom">3.98E-02</td><td valign="bottom">1.81</td><td valign="bottom">0.08</td><td valign="bottom">GO:0004935</td></tr></tbody></table></table-wrap></sec><sec id="s2-2"><title>Atx2 associates preferentially with 3′UTRs of target mRNAs</title><p>The RNA edit sites identified by TRIBE reflect the positions to which ADARcd is targeted via direct or indirect Atx2–mRNA interactions. It is therefore possible to use this information to determine the relative positions and preferred sequences for Atx2 binding on respective mRNAs. By converting the TRIBE edits into metagene coordinates, we found that Atx2 interactions occurred predominantly within 3′UTRs of target mRNAs (69.5%), while the coding region (CDS) and 5′UTR accounted for 26.7% and 4% of edits, respectively (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). All the identified edits occurred almost exclusively in exons (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), which might be due to polyA selection causing experimental bias or that Atx2 binds to only mature mRNA in the cytoplasm. Edits within CDS were often accompanied by edits in the 3′UTR of the same mRNA, further indicating a key role for Atx2–3′UTR interactions (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). Also pointing to a role in 3′UTR regulation, Atx2 edit sites were particularly prevalent in brain transcripts with longer 3′UTRs that are more often subject to translational control (<xref ref-type="bibr" rid="bib27">Inagaki et al., 2020</xref>; <xref ref-type="bibr" rid="bib50">Miura et al., 2013</xref>; <xref ref-type="bibr" rid="bib81">Wang and Yi, 2014</xref>; <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). These observations are consistent with prior work showing that Atx2 can mediate activation or repression of specific mRNA translation via elements in their 3′UTRs (<xref ref-type="bibr" rid="bib39">Lee et al., 2017</xref>; <xref ref-type="bibr" rid="bib42">Lim and Allada, 2013</xref>; <xref ref-type="bibr" rid="bib46">McCann et al., 2011</xref>; <xref ref-type="bibr" rid="bib70">Sudhakaran et al., 2014</xref>; <xref ref-type="bibr" rid="bib89">Zhang et al., 2013</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Atx2</italic> preferentially edits AU-rich sequences in the 3′UTRs of the target mRNAs.</title><p>(<bold>A</bold>) Metaplot analysis showing Atx2 preferentially associates with 3′UTRs of the target mRNA. (<bold>B</bold>) Motif analyses involving ±100 bases around the edit site using MEME identifies AU-rich element sequences in the 3′UTRs of the target mRNAs.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Exon specificity of Atx2 mRNA interactions and sequence selectivity of observed Atx2–coding sequence (CDS) interactions.</title><p>Atx2-ADARcd fusion protein exclusively edits exons, indicating cytoplasmic binding to mature mRNAs.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Atx2-target mRNAs have longer-than-average 3′UTRs.</title><p>Mann–Whitney U test was used to determine the difference in the 3′UTR length between Atx2 targets and brain transcriptome. p-Value is &lt;0.0001, and error bars represent SEM. Bootstraping was performed 1000 times with replacement. Statistics was performed using chi-square test with cutoff (p-value &lt;0.05). Fisher's test was used to combine the p-values.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Coding sequence edits were co-existent with 3'UTR edits.</title><p>(<bold>A</bold>) Coding sequence edits often occurred together with a 3′UTR edit on the same mRNA consistent with an initial Atx2–3′UTR interaction enabling edits to a proximal coding sequence as well. (<bold>B</bold>) A GC-rich motif for Atx2–CDS association indicated by analyses of sequences flanking CDS edit sites.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig2-figsupp3-v1.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>Multiple-sequence alignment was performed for regions around Atx2 binding motifs in <italic>Akh</italic> and <italic>Vmat</italic> genes between <italic>Drosophila melanogaster</italic> and closely related <italic>Drosophila</italic> species.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig2-figsupp4-v1.tif"/></fig></fig-group><p>Further analyses using the MEME suite of tools for motif-based sequence analysis identified an AU-rich element (ARE) ‘UAUAUAUA’ as highly enriched in mRNA target sequences within 100 bases of identified edit sites (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). These AREs, previously implicated in the regulation of mRNA stability, are most abundant near 3′UTR edits sites of the target mRNAs, while a secondary motif with GC-rich sequence was found predominantly for the CDS edits (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>). A multiple-sequence alignment for two of the genes (<italic>Vmat</italic> and <italic>Akh</italic>) shows the motifs in the 3′UTR are conserved between closely related <italic>Drosophila</italic> species (<xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5</xref>). This suggests a model in which Atx2 preferentially associates with ARE-containing 3′UTRs of target mRNAs to regulate their stability in vivo either by directly binding the target mRNA or indirectly via another ARE-binding protein.</p></sec><sec id="s2-3"><title>Atx2 stabilizes the majority of its mRNA targets</title><p>AREs are major <italic>cis</italic>-regulatory motifs in the 3′UTR of mRNAs that regulate their stability (<xref ref-type="bibr" rid="bib54">Otsuka et al., 2019</xref>; <xref ref-type="bibr" rid="bib78">Vasudevan and Peltz, 2001</xref>). For this reason, several RBPs modulate mRNA stability by binding to AREs and regulating their accessibility to RNA degradative machinery (<xref ref-type="bibr" rid="bib45">Mayya and Duchaine, 2019</xref>). For example, Pumilio binding to ARE increases degradation, while HuR binding stabilizes the mRNAs (<xref ref-type="bibr" rid="bib43">López de Silanes et al., 2004</xref>; <xref ref-type="bibr" rid="bib82">Weidmann et al., 2014</xref>). To ask how Atx2 binding alters target mRNA stability, we expressed a previously validated Atx2-targeting RNAi construct in fly brains to reduce endogenous Atx2 expression and used RNAseq to determine how this affected the steady-state levels of Atx2-target and non-target mRNAs (<xref ref-type="bibr" rid="bib46">McCann et al., 2011</xref>; <xref ref-type="bibr" rid="bib70">Sudhakaran et al., 2014</xref>).</p><p>Experimental <italic>elav-Gal4, UAS-Atx2-RNAi; Tub-Gal80<sup>ts</sup></italic> flies were reared to adulthood at 18°C. They were then transferred to 29°C to inactivate Gal80<sup>ts</sup> and enable neural Atx2-RNAi expression for 5 days before isolating total RNA from brain (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). RNAseq data confirmed partial knockdown of Atx2 mRNA in experimental flies expressing Atx2-RNAi (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Immunoblots might not reflect this at the protein level likely because the expression of RNAi is restricted to <italic>elav</italic> neurons, which are difficult to isolate and analyze, hence we verified Atx2 RNAi efficiency in the wing disc using <italic>ptc-Gal4</italic>. Atx2 levels were down only in the Gal4-expressing cells compared to the neighboring control cells (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Atx2<italic>–ARE</italic> interactions modulate mRNA stability.</title><p>(<bold>A</bold>) Schematic of strategy to induce RNAi expression specifically in adult fly brain. Total RNA extracted from brain post 5 days at 29°C was sequenced using Illumina 2500 and differential expression analyzed using DESeq2. (<bold>B</bold>) Normalized mRNA read counts showing Atx2 mRNA levels to be significantly reduced following RNAi expression compared to Gal4 control with a p-value of &lt;0.0298 using Student’s t-test. (<bold>C</bold>) Effect on Atx2-target mRNAs following Atx2 knockdown: the majority are reduced in level, indicating a role for Atx2 is target stabilization. Bootstraping was performed 1000 times with replacement. Statistics was performed using chi-square test with cutoff (p-value &lt;0.05). Fisher’s test was used to combine the p-values. (<bold>D</bold>) ARE<italic>Score</italic> analysis showing AU-rich elements (AREs) to be enriched in Atx2-target mRNAs compared to the brain transcriptome. (<bold>E</bold>) Among Atx2-target mRNAs, higher ARE scores are seen in mRNAs whose levels are reduced following Atx2 knockdown.</p><p> <supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Data related to <xref ref-type="fig" rid="fig3">Figure 3C</xref>.</title><p>Fold changes in Atx2-target mRNAs upon Atx2 RNAi.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60326-fig3-data1-v1.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Data related to <xref ref-type="fig" rid="fig3">Figure 3E</xref>.</title><p>Correlation of ARE<italic>Score</italic> and target mRNA levels.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60326-fig3-data2-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><italic>Atx2</italic> RNAi knockdown reduces Atx2 expressions.</title><p><italic>Ptc-Gal4</italic> was used to drive Atx2 RNAi in <italic>Drosophila</italic> wing disc and immunostained with anti-beta-Gal (<bold>A</bold>) and anti-Atx2 (<bold>B</bold>) antibodies. Atx2 levels are reduced in the Gal4-expressing cells (<bold>C</bold>).</p><p> <supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Data related to RNAseq mapping percentage from Gal4 and Atx2 RNAi brains.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60326-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Correlation between ARE<italic>Score</italic> and relative expression levels of Atx2-downregulated targets for three biological replicates (selected based on a p-value&lt;0.05).</title><p>Heatmap indicates relative expression levels for each mRNA in control and experimental brain samples. Light gray bars represent Atx2-target mRNAs without significant ARE<italic>Score.</italic></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Differential expression analysis of intron reads from control and Atx2 RNAi show no major reduction in levels of Atx2 Targets of RNA-Binding Proteins Identified by Editing nascent mRNA targets.</title><p> <supplementary-material id="fig3s3sdata1"><label>Figure 3—figure supplement 3—source data 1.</label><caption><title>Fold changes in the introns of Atx2-target mRNAs upon Atx2 RNAi.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60326-fig3-figsupp3-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig3-figsupp3-v1.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>Comparative analyses of Atx2 targets in <italic>Drosophila</italic> brain and S2 cells.</title><p>(<bold>A</bold>) Comparison of Atx2 S2 cell Targets of RNA-Binding Proteins Identified by Editing (TRIBE) targets with <italic>Drosophila</italic> brain TRIBE targets. (<bold>B</bold>) Metaplot showing Atx2 preferentially associates with 3′UTRs of target mRNAs in S2 cells.</p><p> <supplementary-material id="fig3s4sdata1"><label>Figure 3—figure supplement 4—source data 1.</label><caption><title>Percentage edits of Atx2-target mRNAs in S2 cells among RNAseq replicates.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60326-fig3-figsupp4-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig3-figsupp4-v1.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 5.</label><caption><title>Altering levels of Atx2 in S2 cells affects the levels of target mRNAs.</title><p>(<bold>A</bold>) Knockdown of Atx2 using dsRNA in S2 cells. Western blots with anti-Atx2 antibody and anti-tubulin show significant reduction in Atx2 levels. (<bold>B</bold>) Knockdown of Atx2 in S2 cells destabilizes majority of its Targets of RNA-Binding Proteins Identified by Editing targets, which are stabilized in overexpression, indicating a role for Atx2 is target stabilization.</p><p> <supplementary-material id="fig3s5sdata1"><label>Figure 3—figure supplement 5—source data 1.</label><caption><title>Fold changes in Atx2-target mRNAs when Atx2 is overexpressed or knocked down in S2 cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60326-fig3-figsupp5-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig3-figsupp5-v1.tif"/></fig><fig id="fig3s6" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 6.</label><caption><title>ARE<italic>Score</italic> correlate directly with the stability of Atx2-target mRNAs in S2 cells.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig3-figsupp6-v1.tif"/></fig></fig-group><p>Atx2 knockdown caused a significant reduction in levels of over 53.2% of the Atx2-target mRNAs, indicating a broad role for Atx2 in target-mRNA stabilization (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). This was, however, not universal, and we observed that the levels of ~8.8% of the target mRNAs were increased with Atx2 knockdown. Non-target mRNA levels were substantially less affected: ~22.5% of all mRNAs from the global brain transcriptome were reduced by Atx2 knockdown, with ~57.2% showing no detectable change in expression levels (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In contrast, the analysis of nascent transcripts using intron reads showed that predominant Atx2 targets (~85%) remain unchanged (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>), suggesting that the downregulation of target mRNAs in Atx2 RNAi is posttranscriptional.</p><p>To further validate the above results, TRIBE analysis was performed in <italic>Drosophila</italic> S2 cells. Atx2-ADARcd edited ~179 mRNA targets preferentially in the 3′UTR in S2 cells (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4A, B</xref>). The targets identified from S2 cell TRIBE only marginally overlapped with the targets identified in the <italic>Drosophila</italic> brain (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4A</xref>). This minimal overlap could be due to the RNA expression differences between the brain and S2 cells and/or target specificity of Atx2 in different cell types. It has been previously noticed that RNA-binding proteins can bind different RNA targets even within different neuronal populations (<xref ref-type="bibr" rid="bib47">McMahon et al., 2016</xref>).</p><p>Like in brain, Atx2 silencing in S2 cells caused reduction in the levels of significant percentage of targets (~49%) compared to ~14% of total S2 transcripts (<xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5A, B</xref>). In contrast, ~74% of targets that showed reduced expression in Atx2 RNAi were upregulated in Atx2 overexpression (<xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5B</xref>).</p><p>Together, the RNAseq data (1) provide additional evidence in support of in vivo interactions between Atx2 and target mRNAs identified by TRIBE analysis and (2) are consistent with Atx2 binding to the ARE motif acting predominantly to stabilize target mRNAs.</p><p>ARE<italic>Score</italic> is a numerical assessment of ARE strength with high scores correlating to reduced RNA stability in reporter assays (<xref ref-type="bibr" rid="bib69">Spasic et al., 2012</xref>). In support of a broad role for Atx2 in the regulation of ARE function in neurons, UTRs with high ARE<italic>Score</italic> are clearly enriched in the Atx2-target mRNAs compared to the general neural transcriptome (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Further, within the group of Atx2-target RNAs identified by TRIBE, higher ARE<italic>Score</italic> strongly predict mRNAs whose steady-state levels are reduced by Atx2 knockdown in brain and S2 cells (<xref ref-type="fig" rid="fig3">Figure 3E,</xref> <xref ref-type="fig" rid="fig3s6">Figure 3—figure supplement 6</xref>). These results indicate that Atx2 stabilizes a subset of its target mRNAs by binding to AREs.</p><p>The data also point to alternative and/or context-specific mechanisms for mRNA regulation by Atx2. For instance, some Atx2-target mRNAs lack AREs and a significant subset of ARE containing target mRNAs are not destabilized by Atx2 knockdown (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). These could be explained by alternative pathways by which Atx2 is recruited to mRNAs, for example, via microRNA pathway components (<xref ref-type="bibr" rid="bib46">McCann et al., 2011</xref>; <xref ref-type="bibr" rid="bib70">Sudhakaran et al., 2014</xref>) or by further layers of regulation conferred by additional RBPs recruited onto target mRNAs.</p><p>To further understand the mechanisms by which Atx2 interacts with its target mRNAs, we asked which domains of Atx2 might be required for this function. In particular, we asked whether the unstructured IDR or structured Lsm/LsmAD domains contributed to the specificity of Atx2–mRNA target interactions.</p></sec><sec id="s2-4"><title>The cIDR domain enables and the Lsm domain opposes Atx2 interactions with target mRNA</title><p>Atx2 has three structured domains (Lsm, LsmAD, and PAM2) embedded within extended, poorly structured regions of the protein (<xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref>). Although interactions mediated by structured domains in vivo are necessary for normal organismal viability in <italic>Drosophila</italic>, the mechanism by which structure domains function is only clear for PAM2, which, by binding to polyA binding protein PABP, likely allows interactions with polyA tails of mRNAs (<xref ref-type="bibr" rid="bib64">Satterfield and Pallanck, 2006</xref>). In contrast, the most prominent disordered regions in Atx2 (mIDR and cIDR) contribute little to animal viability but are selectively required for the assembly of mRNPs in neurons or cultured cells (<xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref>). To test how Lsm, LsmAD, and cIDR domains of Atx2 contribute to the specificity of mRNA target interactions, we performed TRIBE analyses with specific domain-deleted forms of Atx2 (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Because purified Lsm domain alone as well as Lsm+LsmAD domains has been reported to bind the AU-rich sequences in vitro, we generated transgenes expressing a construct with Lsm+LsmAD domains of Atx2 fused to the catalytic domain of ADAR (<xref ref-type="bibr" rid="bib88">Yokoshi et al., 2014</xref>). In addition, we created transgenic lines expressing Atx2 deleted for either Lsm, LsmAD, mIDR, or cIDR domains based on the UAS-Atx2-ADARcd construct scaffold (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Using the same approach as earlier, we analyzed how each of the domain deletions affected the Atx2-target binding in adult neurons.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Atx2 requires its cIDR domain for interaction with its target mRNA.</title><p>(<bold>A</bold>) An illustration of domains of Atx2. The structured (Like-Sm [Lsm] and Lsm-associated [LsmAD]) and disordered domains (mIDR and cIDR) of Atx2 protein were deleted one at a time to understand the domains necessary for its interaction with target RNA. The wild-type Atx2 and the deletions contained a c-terminal ADARcd and V5 tag. The deletions are shown by the dotted lines. (<bold>B</bold>) Deletion of LsmAD or mIDR domain reduced the ability of Atx2 to interact with its targets, while cIDR deletion almost entirely prevented Atx2 mRNA interactions. The Lsm-domain deletion showed an overall increase in mRNA edits. (<bold>C</bold>) More detailed heatmap view of individual target mRNAs showing target edit percentages in flies expressing control or domain-deleted forms Atx2 fused to ADARcd. (<bold>D</bold>) Most of the apparently new targets identified in Atx2∆Lsm Targets of RNA-Binding Proteins Identified by Editing analyses are also edited, albeit at a lower efficiency, in flies expressing full-length Atx2-ADAR fusions. This suggests that deletion of the Lsm domain increases the interaction of Atx2 with its native target mRNAs. (For <bold>C</bold> and <bold>D</bold>, 15% threshold edits identified for samples in column 1 [Atx2 WT in <bold>C</bold> and Atx2∆Lsm in <bold>D</bold>] was used to compare with all the edits of the rest of the columns to generate a heatmap.)</p><p> <supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Data related to <xref ref-type="fig" rid="fig4">Figure 4B</xref>.</title><p>mRNA targets identified for different Atx2 domain deletions.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60326-fig4-data1-v1.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Data related to <xref ref-type="fig" rid="fig4">Figure 4C, D</xref>.</title><p>Edit percentages for Atx2-target mRNAs identified using different domain deletions.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60326-fig4-data2-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Atx2 Like-Sm (Lsm), Lsm-associated (LsmAD), or mIDR domains are not essential for AU-rich motif preference.</title><p>MEME analysis showing Atx2 preferentially associates with AU-rich motif on target mRNA. Deletion of Lsm, LsmAD, or mIDR domains does not block the Atx2 AU-rich motif preference. Unique targets found in Lsm domain deletion have a GC-rich motif preference, which is also identified as the second most predominant motif that Atx2 WT bind.</p><p> <supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Mapping percentage for different Atx2 deletions.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60326-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Atx2∆Lsm unique targets were present at a reduced edit threshold in Atx2 WT.</title><p>Several of the Atx2∆Lsm edits found at 15% threshold were found in Atx2 WT edits at 5% threshold.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Equivalent read quality and ADAR expression across Atx2 deletion analyses.</title><p>Poly(A)-enriched mRNA from 10 to 12 brains was sequenced using paired-end libraries on Illumina 2500. (<bold>A</bold>) The reads obtained were comparable between genotypes and of high quality, and mapping to the <italic>Drosophila</italic> genome was &gt;80% for all the samples (<xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref>). (<bold>B</bold>) Quantification for ADAR mRNA as a read out for transgene expression showed expression above the endogenous control and comparable between Atx2 WT and the various mutant transgenic lines. (<bold>C</bold>) Western blots with anti-V5 antibody show levels of Atx2 transgene expression in <italic>Drosophila</italic> brain among transgenic lines.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig4-figsupp3-v1.tif"/></fig></fig-group><p>Initial observations indicated that Lsm+LsmAD domains on their own could not efficiently target ADAR to mRNA: transcripts sequenced from Lsm+LsmAD-ADARcd-expressing brains contained negligible edits, which did not overlap significantly with Atx2 targets (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Therefore, the Lsm and LsmAD domains are insufficient to drive Atx2–mRNA interactions in vivo. Further, deletions of either Lsm or LsmAD did not block the ability of Atx2 to interact with most TRIBE targets: thus, they appear neither necessary nor sufficient for Atx2 targeting to these mRNAs (<xref ref-type="fig" rid="fig4">Figure 4B, C</xref>). These surprising observations led us to examine the role of disordered domains in driving Atx2–mRNA interactions in vivo.</p><p>In contrast to the effects of deleting the Lsm domain, deletion of cIDR abolished Atx2 binding to most target mRNAs (<xref ref-type="fig" rid="fig4">Figure 4B, C</xref>). As the cIDR plays a major role in mRNP assembly (<xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref>), this unexpected observation suggests that Atx2 moves into proximity of target mRNAs only after cIDR-mediated granule formation. Deletion of the mIDR resulted only in a relatively minor reduction in target binding, but this is consistent with prior work indicating only a minor role in mRNP assembly (<xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref>). In addition, the deletion of Lsm, LsmAD, or mIDR domains did not alter AU-rich motif preference for Atx2, suggesting that these domains do not provide mRNA binding specificity (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Deeper analyses provided additional support for a model in which Atx2 associates to RNA-binding proteins in individual mRNPs, but is brought into closer contact with mRNAs through remodeling events associated with the formation of higher order mRNP assemblies.</p><p>A key observation is that while Lsm-domain deletions did not reduce RNA edits, they also curiously resulted in a significantly larger number of edited target mRNAs compared to the full-length, wild-type Atx2 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). A more detailed analysis showed that several of the apparently novel targets of Atx2∆Lsm were also bound by the wild-type Atx2 but with reduced affinity and were therefore below the threshold of our analysis (<xref ref-type="fig" rid="fig4">Figure 4D,</xref> <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). Because sequencing depth, read quality, and ADAR mRNA and protein levels were similar across control and domain-deletion experiments (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3A–C</xref>), these observations argue that the Lsm domain acts to broadly antagonize physiologically relevant mRNA interactions driven by the cIDR. Thus, while the cIDR domain of Atx2 is essential for its mRNA target interactions, the Lsm domain is inhibitory: in its absence, Atx2 shows an enhanced association with its native, target mRNAs.</p></sec><sec id="s2-5"><title>The Atx2 Lsm domain inhibits cIDR-mediated mRNP granule assembly</title><p>The most parsimonious explanation for the observed opposing effects of Lsm and cIDR domain deletions on mRNA editing (<xref ref-type="fig" rid="fig4">Figure 4</xref>) is that the Lsm domain functions to oppose cIDR-mediated mRNP granule assembly (<xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref>). To directly test this hypothesis, we first asked whether deletion of the Lsm domain enhanced Atx2 RNP assembly. Expression of wild-type C-terminally SNAP tagged Atx2 (Atx2-SNAP) in S2 cells led to the formation of SG-like RNP-granule foci through a mechanism dependent on cIDR as described previously (<xref ref-type="fig" rid="fig5">Figure 5ii, v</xref>; <xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref>). Strikingly consistent with our predictions, expression of Atx2∆Lsm-SNAP constructs lacking the Lsm domain induced significantly larger RNP granules compared to wild-type Atx2-SNAP (<xref ref-type="fig" rid="fig5">Figure 5i</xref>). Similar to wild-type Atx2-SNAP granules, these large Atx2∆Lsm-SNAP-induced granules also contained the SG protein, G3BP/Rasputin (Rin) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>), and their formation required the presence the cIDR (<xref ref-type="fig" rid="fig5">Figure 5iv</xref>). Thus, Lsm domain appears to act antagonistically to cIDR to prevent RNP granule assembly.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Atx2 Like-Sm (Lsm) domain alters granule dynamics.</title><p>(<bold>A</bold>) <italic>Drosophila</italic> S2 cells expressing Atx2 protein with a C-terminal SNAP tag. Atx2∆Lsm form large cytoplasmic granules (i) that are much larger than WT Atx2 granules (ii). Atx2 with an additional Lsm domain in place of mIDR to create 2XLsm forms smaller granules compared to WT Atx2 in S2 cells (iii). Deletion of cIDR domain blocks Atx2 granule formation (iv). In the absence of cIDR, Lsm deletion does not rescue Atx2 granules (v). Domain map along with the granule phenotype is shown in (vi). The scale bar corresponds to 2 µm. (<bold>B</bold>) Radius of the stress granule (size) and (<bold>C</bold>) number of stress granules per cell were quantified and plotted. More than 80 cells per genotype were used for granule quantification.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Granules formed by overexpression of Atx2 and ∆Lsm resemble stress granules (SGs) that also contain SG protein Rasputin (Rin).</title><p>Atx2 WT forms cytoplasmic granules (i) that contain Rin (ii and iii). The deletion of cIDR blocks granule formation (iv, v, and vi). Atx2 granules formed upon Like-Sm (Lsm) domain deletion also resemble Atx2 WT granules and contain SG protein Rin (vii, viii, and ix). The deletion of both Lsm and cIDR domains blocks the ability of Atx2 to form granules (x, xi, and xii). Atx2-2XLsm, where mIDR was replaced with a second Lsm domain, reduces Atx2 granule size but resembles WT granules and contains Rin (xiii, xiv, and xv). The scale bars correspond to 2 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig5-figsupp1-v1.tif"/></fig></fig-group><p>To further confirm this, we tested if the inclusion of additional Lsm domains would reduce the ability of Atx2 to form RNP granules. As the deletion of the Atx2 mIDR does not alter mRNP granule assembly in S2 cells (<xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref>), we replaced mIDR with an additional Lsm domain to create an Atx2 protein with two Lsm domains. Remarkably, Atx2 with two Lsm showed much smaller foci in S2 cells (<xref ref-type="fig" rid="fig5">Figure 5Aiii</xref>). Quantification of granules in these cells reiterated that while ∆Lsm formed fewer but larger granules, increasing the valency of Lsm domains led to the formation of several smaller granules (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). The summary of these results is shown in <xref ref-type="fig" rid="fig5">Figure 5Avi</xref>. Taken together, the observations that deletion of the Lsm enhances and addition of an extra Lsm domain inhibits RNP assembly provide strong support for two opposing activities encoded by the Lsm and cIDR domains of Atx2.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Previous work has shown that <italic>Drosophila</italic> Atx2 functions in neurons as a translational activator of the <italic>period</italic> mRNA that controls circadian rhythms and as a translational repressor of the calcium-calmodulin-dependent kinase CaMKII involved in synaptic plasticity and memory (<xref ref-type="bibr" rid="bib42">Lim and Allada, 2013</xref>; <xref ref-type="bibr" rid="bib70">Sudhakaran et al., 2014</xref>; <xref ref-type="bibr" rid="bib89">Zhang et al., 2013</xref>). Atx2 is also required for the assembly of neuronal mRNPs believed to provide pools of synaptically localized mRNAs whose translation contributes the consolidation of long-term memory (<xref ref-type="bibr" rid="bib46">McCann et al., 2011</xref>). These studies indicate the specific positive and negative translational functions of Atx2, which are mediated by structured–domain interactions with Lsm12 or Me31B/DDX6, respectively (<xref ref-type="bibr" rid="bib39">Lee et al., 2017</xref>), and that mRNP-assembly functions are mediated by its cIDR (<xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref>). However, the generality of these mechanisms, the range of neuronal mRNAs and neuronal functions under Atx2 regulation, as well as how structured and disordered domain interactions are coordinated remain largely unknown. Here, by deploying and building on TRIBE analysis to identify a suite of Atx2-target mRNAs, we address these questions and provide insights of relevance for biology, technology, and medicine.</p><sec id="s3-1"><title>Neural functions of Ataxin-2</title><p>TRIBE allows in vivo RNA targets of RBPs to be identified from small tissue samples, eliminating several technical challenges and artifacts associated with immunoprecipitation-based methods (<xref ref-type="bibr" rid="bib29">Jin et al., 2020</xref>; <xref ref-type="bibr" rid="bib47">McMahon et al., 2016</xref>; <xref ref-type="bibr" rid="bib86">Xu et al., 2018</xref>). This method led to the identification of 256 <italic>Drosophila</italic> brain mRNAs that associate with Atx2 with the proximity and stability required for Atx2-linked enzymatic editing of the mRNA. These mRNAs are reproducibly identified in replicate experiments and do not show any over-representation of highly expressed mRNAs. Moreover, the observation that a substantial fraction of these mRNAs either have AREs in their 3′UTRs and/or show altered steady-state levels following Atx2 knockdown argues that the majority represent real Atx2 targets and not non-specific proximity-based editing events that can sometimes occur within RNP complexes (<xref ref-type="bibr" rid="bib10">Biswas et al., 2020</xref>). Thus, the resulting robust data set of Atx2 targets may provide valuable hypotheses for biological functions and genetic pathways regulated by Atx2. For instance, a striking enhancement of mRNAs encoding specific neuropeptides and neuronal hormones suggests that altered intercellular communication mediated by their translational regulation may contribute to the behavioral plasticity associated with circadian time or long-term memory. Similarly, a large subset of target mRNAs encoding proteins regulating neural excitability through multiple different mechanisms is unexpected and points to the possibility that activity-regulated translation may act via local changes in membrane properties to achieve localized plasticity required for encoding specific memories. It is important to note that this analysis may miss mRNAs that are strong targets in a small subset of neurons but not in others, for instance, the other cells may express RBPs that prevent Atx2 interactions. Thus, more targets may be found by new approaches using TRIBE for single-cell analyses (<xref ref-type="bibr" rid="bib47">McMahon et al., 2016</xref>).</p><p>But not all Atx2-regulated mRNAs have been identified. It is notable that two of the best-established Atx2 targets, CaMKII and <italic>per,</italic> were not identified by TRIBE. While the <italic>per–</italic>Atx2 interactions, being time- and cell-type restricted (<xref ref-type="bibr" rid="bib42">Lim and Allada, 2013</xref>; <xref ref-type="bibr" rid="bib89">Zhang et al., 2013</xref>), could potentially be missed for statistical reasons, this is unlikely the case for CaMKII, a highly expressed mRNA that co-immunoprecipitates with Atx2 (<xref ref-type="bibr" rid="bib70">Sudhakaran et al., 2014</xref>). We suggest instead that these represent Atx2 targets missed by TRIBE because they are regulated through relatively indirect mechanisms that do not require close contact between Atx2 and the mRNA. For instance, in case of <italic>per</italic>, its 3′UTR is recognized by the sequence-specific RBP Twentyfour (TYF), which recruits Atx2 that in turns recruits a Lsm12-containing complex to the <italic>per</italic> 3′UTR, thus allowing translational activation (<xref ref-type="bibr" rid="bib39">Lee et al., 2017</xref>). Similarly, for CaMKII, Atx2 may be recruited by miRNA pathway components and act via co-regulators such as Me31B/DDX6, through mechanisms that do not rely on close proximity between Atx2 and target mRNAs. The above may also help explain why previously proposed target mRNAs in metabolic pathways for instance are not represented in this data set (<xref ref-type="bibr" rid="bib88">Yokoshi et al., 2014</xref>). Indeed, Atx2 likely binds to several additional neuronal mRNAs not identified by TRIBE, which requires Atx2 proximity to the mRNA. Such targets may be better identified by CLIP-based methods. However, considerable new understanding can be provided by the detailed analysis of the 256 robust targets identified here by TRIBE.</p><p>One important insight is the discovery of a broad function for Atx2 in neuronal mRNA stabilization. Atx2 associates preferentially to 3′UTRs of the target-mRNAs, and particularly to AU-rich sequences (AREs) in these UTRs (<xref ref-type="fig" rid="fig2">Figure 2</xref>). AREs are common <italic>cis</italic>-regulatory features regulating mRNA stability, a posttranscriptional gene regulation strategy adopted by all eukaryotic cells (<xref ref-type="bibr" rid="bib23">García-Mauriño et al., 2017</xref>). The observation that knockdown of Atx2 in <italic>Drosophila</italic> brain and S2 cells causes levels of a large fraction of the Atx2-target mRNAs to be significantly reduced (<xref ref-type="fig" rid="fig3">Figure 3B, C</xref>, <xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5B</xref>) and that the most downregulated targets have strong ARE<italic>Score</italic> (<xref ref-type="bibr" rid="bib69">Spasic et al., 2012</xref>) suggests that Atx2 directly or indirectly associates with AREs to protect mRNAs from degradation (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). This could be achieved by blocking ARE-dependent recruitment of RNA degradation complexes through a mechanism similar to that described previously for HuR (<xref ref-type="bibr" rid="bib56">Peng et al., 1998</xref>). These conclusions may also be relevant for mammalian Atxn2 as physical interactions between mammalian Atxn2 and AREs have been described previously using PAR-CLIP analyses from cultured HEK293 cells (<xref ref-type="bibr" rid="bib88">Yokoshi et al., 2014</xref>). Moreover, Atxn2-CAG100-KnockIn mouse engineered to express polyQ expanded forms of Atxn2 that should enhance granule formation show a predominant upregulation of mRNAs, consistent with a role for Atx2-mediated mRNP assembly in stabilizing target mRNAs (<xref ref-type="bibr" rid="bib68">Sen et al., 2019</xref>).</p><p>It is important to note that some mRNAs with high ARE scores do not appear to be stabilized by Atx2, and conversely, some that do not contain AREs appear to be affected by Atx2 knockdown (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Both of these observations are consistent with additional layers and mechanisms of regulation conferred by co-regulating RBPs: either by providing an alternative pathway for ARE regulation via, for instance, miRNA binding (<xref ref-type="bibr" rid="bib71">Sun et al., 2010</xref>; <xref ref-type="bibr" rid="bib75">van Kouwenhove et al., 2011</xref>) or an alternative mechanism for recruitment of Atx2 to the 3′UTR of mRNAs.</p></sec><sec id="s3-2"><title>Mechanisms of Ataxin-2 function in RNP granule assembly</title><p>Our work provides two insights into the mechanisms of mRNP formation. First, it indicates that individual mRNPs may be substantially remodeled as they assemble into higher order mRNP assemblies. In support of this, we show that Atx2 lacking its cIDR, which cannot form granules, is also not associated closely enough with mRNAs to allow their editing by a linked ADAR catalytic domain. One possibility is that mRNP remodeling is driven by major conformational changes in RBPs, which not only increase their propensity to drive mRNP condensation but also result in altered RBP–RBP and RBP–RNA interactions. In this context, recent work on G3BP/Rin has shown that the protein exists in two dramatically different conformational states: a closed form, in which its IDRs are inaccessible for condensation reactions, and a dephosphorylation-induced open form, capable of mediating SG association (<xref ref-type="bibr" rid="bib24">Guillén-Boixet et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Laver et al., 2020</xref>; <xref ref-type="bibr" rid="bib63">Sanders et al., 2020</xref>). In such a framework, it is easy to see how Atx2 interactions with RBPs and mRNAs could be altered under conditions that support granule assembly. While these changes in Atx2 interactions could occur due to structural changes in other components of Atx2-containing mRNPs, our second insight is that alterations in the Atx2 protein itself probably occur and contribute to driving granule assembly.</p><p>Ataxin-2 is a modular protein capable of association with multiple translational control components (<xref ref-type="bibr" rid="bib17">Dansithong et al., 2015</xref>; <xref ref-type="bibr" rid="bib35">Lastres-Becker et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Lee et al., 2017</xref>; <xref ref-type="bibr" rid="bib64">Satterfield and Pallanck, 2006</xref>; <xref ref-type="bibr" rid="bib72">Swisher and Parker, 2010</xref>). Although Atx2 lacks RNA recognition domains like RRMs, KH, or other previously characterized RNA-binding domains, homology-based modeling studies and indirect experimental observations have suggested that the Lsm domain of Atx2 may mediate RNA interaction (<xref ref-type="bibr" rid="bib13">Calabretta and Richard, 2015</xref>; <xref ref-type="bibr" rid="bib26">Hentze et al., 2018</xref>; <xref ref-type="bibr" rid="bib88">Yokoshi et al., 2014</xref>). However, direct experimental tests of this hypothesis show that close Atx2 interactions with mRNA, as assessed by TRIBE, are actively prevented by the Lsm domain, which also opposes mRNP assembly (<xref ref-type="fig" rid="fig4">Figure 4</xref> and <xref ref-type="fig" rid="fig5">Figure 5</xref>). In contrast, the cIDR that drives mRNP assembly is necessary for Atx2-coupled editing of target mRNA. An untested prediction of this model is that the TRIBE analysis of Atx2 forms carrying Lsm domain repeats would yield results similar to those seen after cIDR deletion.</p><p>The simplest explanation for these findings is that Atx2 association with individual, potentially translationally active mRNPs in the soluble phases is mediated by Lsm domain–RBP interactions that also occlude or prevent cIDR-mediated mRNP assembly (<xref ref-type="bibr" rid="bib14">Ciosk et al., 2004</xref>; <xref ref-type="bibr" rid="bib39">Lee et al., 2017</xref>; <xref ref-type="bibr" rid="bib64">Satterfield and Pallanck, 2006</xref>). Conditions that promote mRNP assembly disrupt Lsm-domain-mediated interactions and enable cIDR-driven granule formation (<xref ref-type="fig" rid="fig6">Figure 6</xref>). We note that recent work on G3BP has beautifully elaborated phosphorylation-regulated intramolecular interactions that similarly allow the molecule to switch between soluble and assembly-competent conformations (<xref ref-type="bibr" rid="bib24">Guillén-Boixet et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Laver et al., 2020</xref>; <xref ref-type="bibr" rid="bib63">Sanders et al., 2020</xref>). Though our experiments do not yet define molecular and biophysical details by which Atx2 transitions from assembly-inhibited to assembly-competent states, our observations (1) clearly demonstrate crucial opposing, physiological roles of the Lsm and cIDR domains in this process and (2) suggest that regulation of intermolecular interactions mediated by the Lsm domain will be involved in control of Atx2-mediated granule assembly.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Ataxin-2 domains in mRNA target regulation.</title><p>A model to explain the current and previous observations on Ataxin-2 as well as its function in mRNA regulation. (<bold>A</bold>) Ataxin-2 does not make direct contact with mRNAs in soluble mRNPs. Instead, it is recruited to RNA by other RBPs that bind to structured Like-Sm (Lsm) (or Lsm-associated [LsmAD]) domains. In these soluble mRNPs, the cIDR is buried and inaccessible. One class of mRNP (above) contains AU-rich elements (AREs); the second class below (e.g., <italic>per</italic> in <italic>Drosophila</italic>) does not. (<bold>B</bold>) Under specific signaling conditions (e.g., stress), RBP–Atx2 interactions are prevented. In these ‘remodeled’ mRNPs, the Atx2-cIDR is exposed. We speculate that a segment of this intrinsically disordered domain (IDR) directly binds to nearby AREs (or to ARE-binding proteins), while other segments of the IDR mediate multivalent interactions that contribute to mRNP condensation. (<bold>C</bold>) Ataxin-2 cIDR interactions enable mRNP assembly into granules, facilitated by RNA–RNA crosslinks and interactions mediated by other RBPs (e.g., G3BP/Rin). These RNP granules may include both ARE-containing mRNAs (edited) and mRNAs that do not. Note that additional RBPs (red) could determine not only Atx2 proximity to specific mRNAs (leading to editing) but also the effect of Atx2 on mRNA translation and/or stability. These and alternative models remain to be tested.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60326-fig6-v1.tif"/></fig><p>It is important to note that Ataxin-2 has additional essential functions beyond those described here. In particular, given that the Atx2 structured domains not required for TRIBE-target binding are essential for survival, unlike the IDR, which is required for editing of TRIBE targets but not for animal survival, it appears likely that a class of Atx2-target mRNAs is regulated outside of mRNP granules through largely structured-domain interactions (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Additional approaches and experiments are required to identify such mRNAs as well as mechanisms by which they are regulated.</p></sec><sec id="s3-3"><title>Insight for disease and therapeutics</title><p>Ataxin-2 has attracted considerable clinical interest for three main reasons. First, assembly-promoting mutations in the Ataxin-2 gene or associated RNA binding and SG proteins such as TDP-43 can cause neurodegenerative disease. Second, SG proteins such as TDP-43 are usually present in cytoplasmic protein inclusions associated with familial and heritable forms of ALS and FTD. Third, reduction of Ataxin-2 can slow neurodegeneration in animal models of ALS, indicating that the normal function of Ataxin-2 is required for initiation or progression of disease (<xref ref-type="bibr" rid="bib7">Becker et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Scoles et al., 2017</xref>). These findings, interpreted in a framework wherein SGs are thought to facilitate the nucleation of pathogenic amyloid filaments, have led to the development of therapeutics based on reducing levels of Ataxin-2, for example, using antisense oligonucleotides by major companies such as Ionis and Biogen Inc. In this context, the discovery that the Lsm domain inhibits mRNP assembly suggests, first, that mutations inactivating this domain could have effects similar to polyQ expansions and promote disease and, second, that compounds targeting specific domains and activities of Ataxin-2 may prove more effective as therapeutics than those that knock down protein levels.</p><p>The case for our understanding of the function of each Atx2 domain and developing specific modulators is particularly strong since Ataxin-2 protein itself has several important roles not only in mRNA stabilization, as shown here, but also in protein translation, cell signaling, metabolism, and embryonic development (<xref ref-type="bibr" rid="bib25">Halbach et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Inagaki et al., 2020</xref>; <xref ref-type="bibr" rid="bib31">Kato et al., 2019</xref>; <xref ref-type="bibr" rid="bib42">Lim and Allada, 2013</xref>; <xref ref-type="bibr" rid="bib49">Meierhofer et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Yang et al., 2019</xref>; <xref ref-type="bibr" rid="bib88">Yokoshi et al., 2014</xref>; <xref ref-type="bibr" rid="bib89">Zhang et al., 2013</xref>), as shown by various biological studies of native Ataxin-2 function.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top"><italic>UAS-Atx2-WT-ADARcd</italic></td><td valign="top">This paper</td><td valign="top">N/A</td><td>Related to <xref ref-type="fig" rid="fig1">Figures 1</xref>, <xref ref-type="fig" rid="fig2">2</xref> and <xref ref-type="fig" rid="fig4">4</xref></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top"><italic>UAS-Atx2-ΔLsm-ADARcd</italic></td><td valign="top">This paper</td><td valign="top">N/A</td><td>Related to <xref ref-type="fig" rid="fig4">Figure 4</xref></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top"><italic>UAS-Atx2- ΔLsm-AD-ADARcd</italic></td><td valign="top">This paper</td><td valign="top">N/A</td><td>Related to <xref ref-type="fig" rid="fig4">Figure 4</xref></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">(<italic>UAS-Atx2- ΔmIDR-ADARcd</italic>)</td><td valign="top">This paper</td><td valign="top">N/A</td><td>Related to <xref ref-type="fig" rid="fig4">Figure 4</xref></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top"><italic>UAS-Atx2- ΔcIDR-ADARcd</italic></td><td valign="top">This paper</td><td valign="top">N/A</td><td>Related to <xref ref-type="fig" rid="fig4">Figure 4</xref></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top"><italic>UAS-Atx2-only Lsm/Lsm-AD -ADARcd</italic></td><td valign="top">This paper</td><td valign="top">N/A</td><td>Related to <xref ref-type="fig" rid="fig4">Figure 4</xref></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top"><italic>Elav-Gal4; Tub-Gal80<sup>ts</sup></italic></td><td valign="top">Bloomington <italic>Drosophila</italic> Stock center</td><td valign="top"/><td>Related to <xref ref-type="fig" rid="fig3">Figure 3</xref></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top"><italic>UAS-Atx2 RNAi</italic></td><td valign="top">Vienna <italic>Drosophila</italic> RNAi Center stock collection</td><td valign="top">34955</td><td>Related to <xref ref-type="fig" rid="fig3">Figure 3</xref></td></tr><tr><td valign="top">Cell line <break/>(<italic>Drosophila melanogaster</italic>)</td><td valign="top">S2R+ cells</td><td valign="top">DGRC</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_Z831">CVCL_Z831</ext-link></td><td/></tr><tr><td>Recombinant DNA reagent</td><td valign="top">pJFRC7-20XUAS-IVS-8_Atx2-ADARcd <break/>(plasmid)</td><td valign="top">This paper</td><td valign="top">N/A</td><td>Construct to express WT Atx2-ADAR fusion protein</td></tr><tr><td>Recombinant DNA reagent</td><td valign="top">pJFRC7-20XUAS- <break/>IVS-8_Atx2ΔmIDR -ADARcd <break/>(plasmid)</td><td valign="top">This paper</td><td valign="top">N/A</td><td>Construct to express Atx2∆mIDR-ADAR fusion protein</td></tr><tr><td>Recombinant DNA reagent</td><td valign="top">pJFRC7-20XUAS-IVS-8_Atx2ΔcIDR -ADARcd <break/>(plasmid)</td><td valign="top">This paper</td><td valign="top">N/A</td><td>Construct to express Atx2∆cIDR-ADAR fusion protein</td></tr><tr><td>Recombinant DNA reagent</td><td valign="top">pJFRC7-20XUAS-IVS-8_Atx2ΔLsm -ADARcd <break/>(plasmid)</td><td valign="top">This paper</td><td valign="top">N/A</td><td>Construct to express Atx2∆Lsm-ADAR fusion protein</td></tr><tr><td>Recombinant DNA reagent</td><td valign="top">pJFRC7-20XUAS-IVS-8_Atx2ΔLsmAD-ADARcd <break/>(plasmid)</td><td valign="top">This paper</td><td valign="top">N/A</td><td>Construct to express Atx2∆LsmAD-ADAR fusion protein</td></tr><tr><td>Recombinant DNA reagent</td><td valign="top">pJFRC7-20XUAS-IVS-8_Atx2only-Lsm-LsmAD-ADARcd <break/>(plasmid)</td><td valign="top">This paper</td><td valign="top">N/A</td><td>Construct to express only Lsm-LsmAD-ADAR fusion protein</td></tr><tr><td>Antibody</td><td>Anti-Atx2 (chicken polyclonal)</td><td><xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref></td><td/><td>IF (1:500) <break/>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-Rasputin (rabbit polyclonal)</td><td valign="top"><xref ref-type="bibr" rid="bib1">Aguilera-Gomez et al., 2017</xref></td><td/><td>IF (1:500)</td></tr><tr><td>Antibody</td><td>Anti-GFP (rabbit polyclonal)</td><td>Molecular probes</td><td>Cat# A11122</td><td>IF (1:500)</td></tr><tr><td>Antibody</td><td>Anti-GFP (chicken polyclonal)</td><td>Abcam</td><td>Cat# mAb 13970</td><td>IF (1:500)</td></tr><tr><td>Antibody</td><td>Anti-V5 (rabbit polyclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat# sc83849-R</td><td>IF (1:500) <break/>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-nc82 (mouse monoclonal)</td><td><xref ref-type="bibr" rid="bib33">Kittel, 2006</xref></td><td/><td>IF (1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-tubulin (mouse monoclonal)</td><td valign="top">DSHB</td><td valign="top">Cat# E7C</td><td>WB (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 555 (polyclonal goat anti-chicken IgG)</td><td valign="top">Invitrogen</td><td valign="top">Cat# A21437</td><td>IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 488 (polyclonal goat anti-chicken IgG)</td><td valign="top">Invitrogen</td><td valign="top">Cat# A11039</td><td>IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 647 (polyclonal goat anti-chicken IgG)</td><td valign="top">Invitrogen</td><td valign="top">Cat# A21449</td><td>IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 555 (polyclonal goat anti-rabbit IgG)</td><td valign="top">Invitrogen</td><td valign="top">Cat# A21428</td><td>IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 488 (polyclonal goat anti-rabbit IgG)</td><td valign="top">Invitrogen</td><td valign="top">Cat# A11078</td><td>IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 647 (polyclonal goat anti-rabbit IgG)</td><td valign="top">Invitrogen</td><td valign="top">Cat# A21244</td><td>IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 555 (polyclonal goat anti-mouse IgG)</td><td valign="top">Invitrogen</td><td valign="top">Cat# A21422</td><td>IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 488 <break/>(polyclonal goat anti-mouse IgG)</td><td valign="top">Invitrogen</td><td valign="top">Cat# A21121</td><td>IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 647 (polyclonal goat anti-mouse IgG)</td><td valign="top">Invitrogen</td><td valign="top">Cat# A21235</td><td>IF (1:1000)</td></tr><tr><td valign="top">Chemical compound</td><td valign="top">Vectashield Mounting Medium</td><td valign="top">Vector Laboratories</td><td valign="top">Cat# H-1000</td><td/></tr><tr><td valign="top">Chemical compound</td><td valign="top">SNAP-Surface 549</td><td valign="top">New England Biolabs</td><td valign="top">Cat# S9112S</td><td>IF (1:500)</td></tr><tr><td>Software, algorithm</td><td valign="top">TRIBE</td><td valign="top"><xref ref-type="bibr" rid="bib47">McMahon et al., 2016</xref></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://github.com/rosbashlab/TRIBE">https://github.com/rosbashlab/TRIBE</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td valign="top">STAR v2.5.3</td><td valign="top"><xref ref-type="bibr" rid="bib20">Dobin et al., 2013</xref></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://github.com/alexdobin/STAR">https://github.com/alexdobin/STAR</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td valign="top">HTSeq v0.11.2</td><td valign="top"><xref ref-type="bibr" rid="bib3">Anders et al., 2015</xref></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://github.com/htseq/htseq">https://github.com/htseq/htseq</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td valign="top">DESeq2</td><td valign="top"><xref ref-type="bibr" rid="bib44">Love et al., 2014</xref></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/DESeq2.html">https://bioconductor.org/packages/release/bioc/html/DESeq2.html</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td valign="top">ARE<italic>Score</italic></td><td valign="top"><xref ref-type="bibr" rid="bib69">Spasic et al., 2012</xref></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://arescore.dkfz.de/arescore.pl">http://arescore.dkfz.de/arescore.pl</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td valign="top">Guitar</td><td valign="top"><xref ref-type="bibr" rid="bib16">Cui et al., 2016</xref></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/Guitar.html">https://bioconductor.org/packages/release/bioc/html/Guitar.html</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td valign="top">Bedtools</td><td valign="top"><xref ref-type="bibr" rid="bib58">Quinlan and Hall, 2010</xref></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://github.com/arq5x/bedtools2">https://github.com/arq5x/bedtools2</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td valign="top">twoBitToFa</td><td valign="top">-</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://genome.ucsc.edu/goldenPath/help/twoBit.html">https://genome.ucsc.edu/goldenPath/help/twoBit.html</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td valign="top">MEME suite</td><td valign="top"><xref ref-type="bibr" rid="bib5">Bailey et al., 2009</xref></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://meme-suite.org/tools/meme">http://meme-suite.org/tools/meme</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td valign="top">Cellprofiler</td><td valign="top"><xref ref-type="bibr" rid="bib48">McQuin et al., 2018</xref></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://cellprofiler.org">https://cellprofiler.org</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td valign="top">ImageJ</td><td valign="top"><xref ref-type="bibr" rid="bib65">Schneider et al., 2012</xref></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td valign="top">Ggplot2</td><td valign="top"><xref ref-type="bibr" rid="bib83">Wilkinson, 2011</xref></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://github.com/tidyverse/ggplot2">https://github.com/tidyverse/ggplot2</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td valign="top">Pheatmap</td><td valign="top"/><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/pheatmap/index.html">https://cran.r-project.org/web/packages/pheatmap/index.html</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td valign="top">SnapDragon</td><td valign="top"/><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.flyrnai.org/snapdragon">https://www.flyrnai.org/snapdragon</ext-link></td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Generation and rearing of <italic>Drosophila</italic> stocks</title><p><italic>Drosophila</italic> stocks were maintained at 25°C in corn meal agar, and experimental fly crosses were done as specified in the respective experimental methods. The list of <italic>Drosophila</italic> stocks used and transgenic flies generated for this study are given in Key resources table.</p></sec><sec id="s4-2"><title>S2 cell culture</title><p><italic>Drosophila</italic> S2R+ cells were obtained from DGRC and cultured in Schneider’s medium with 10% FBS, penicillin, and streptomycin at 25°C.</p></sec><sec id="s4-3"><title>Creation of transgenic animals</title><p><italic>Drosophila</italic> Atx2 full-length cDNA was cloned into pJFRC7-20XUAS-IVS-8_ADARcd plasmid (a gift from Rosbash Lab) to create pJFRC7-20XUAS-IVS-8_Atx2wt-ADARcd plasmid. Domain deletions were created using overlapping PCR and Gibson assembly or non-overlapping PCR and ligation using pJFRC7-20XUAS-IVS-8_Atx2wt-ADARcd as template. Sequence-confirmed plasmids were used to generate transgenic <italic>Drosophila</italic> using PhiC31 integrase-dependent site-specific insertion of the transgene on the second chromosome. Details of plasmids used for transgenesis are listed in Key resources table. Embryo injections were performed at NCBS transgenic fly facility. Primers used for domain deletions are listed in Key resources table. The sequences of primers used for generating Atx2 domain deletions are provided in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-4"><title>Experimental fly crosses</title><p>Strains homozygous for the <italic>elav-Gal4</italic> and <italic>tub-Gal80<sup>ts</sup></italic> transgenes were crossed with homozygous UAS-transgenic flies at 18°C till the adult fly emerged. One-day-old adult flies from the crosses were maintained at 29°C for 5 days before processing for RNA extraction.</p></sec><sec id="s4-5"><title>S2 cell transfections for immunofluorescence</title><p>Half a million cells were transfected with 500 ng plasmid using Mirus TransIT-X2 Dynamic Delivery System (MIR6000) as per the manufacturer’s instructions. The cells were harvested 24 hr after transfection and processed for immunofluorescence.</p></sec><sec id="s4-6"><title>Double-stranded (ds) RNA generation and S2 cell transfection</title><p>Mock and Atx2 RNAi was performed using dsRNA produced by in vitro transcription (IVT). For mock, we used a GFP sequence from open reading frame. Atx2 RNAi target sites were chosen using SnapDragon tool (<ext-link ext-link-type="uri" xlink:href="https://fgr.hms.harvard.edu/snapdragon">https://fgr.hms.harvard.edu/snapdragon</ext-link>). PCR-generated DNA template containing the T7 promoter sequence at both the ends was used as IVT template for dsRNA synthesis using Megascript T7 High Yield Transcription kit (AM1334; Invitrogen). Half a million cells were transfected with 5 µg of mock or <italic>Atx2</italic> dsRNA using Effectene Transfection reagent (Qiagen 301425) as per the manufacturer’s instructions. After 48 hr of the first round of transfections, cells were again transfected with 5 µg of respective dsRNAs. The sequences of primers used for generating dsRNAs are provided in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-7"><title>RNA extraction from brain and NGS</title><p>Total RNA was isolated from adult brain (10–12 brains per replicate) dissected in RNA Later using TRIzol reagent (Invitrogen) as per the manufacturer’s protocol. Illumina libraries were prepared from Poly(A)-enriched mRNA using NEBNext Ultra II Directional RNA Library Prep kit (E7765L) or TruSeq RNA Library Preparation Kit V2 (RS-122-2001) and sequenced with Illumina HiSeq 2500 system. Atx2-wt TRIBE samples were sequenced using HiSeq SBS Kit v4 (FC-401-4003) producing 2 × 125 paired-end non-strand-specific reads. TRIBE for all the Atx2 domain mutants were sequenced using HiSeq PE Rapid Cluster Kit v2 (PE-402-4002) to generate 2 × 100 paired-end strand-specific data.</p></sec><sec id="s4-8"><title>Western blotting</title><p>Total protein extracts were prepared from S2 cells as described earlier (<xref ref-type="bibr" rid="bib70">Sudhakaran et al., 2014</xref>). Also, 100 µg protein was loaded for detecting Atx2 and 5 µg for tubulin on 6% and 12% SDS-PAGE gels, respectively, and proteins were transferred to PVDF membrane. The blots were probed using chicken anti-Atx2 (1:1000) and mouse anti-tubulin (1:2000). Corresponding HRP-conjugated secondary antibodies were used at 1:10,000 dilution and developed using SuperSignal West Pico Chemiluminescent Substrate as per the manufacturer’s instructions. For detecting V5-tagged ADAR proteins, lysates from fly heads were used as described previously (<xref ref-type="bibr" rid="bib22">Emery, 2007</xref>). Briefly, 10 heads were crushed using plastic pestles in 40 µl extraction buffer (20 mM HEPES pH7.5, 100 mM KCl, 5% glycerol, 10 mM EDTA, 0.1% Triton, 1 mM DTT, 0.5 mM PMSF, 20 mg/ml aprotinin, 5 mg/ml leupeptin, 5 mg/ml pepstatin A). The lysates were cleared by centrifugation at 12,000 <italic>g,</italic> and equal amounts of protein lysates were loaded on a 6% SDS-PAGE gel. Western blots were probed using rabbit anti-V5 (sc83849-R) antibody (1:1000) or mouse anti-tubulin (1:2000) overnight at 4°C. Blots were developed as described above.</p></sec><sec id="s4-9"><title>TRIBE data analysis</title><p>All sequencing reads obtained post adaptor removal had a mean quality score (Q-Score) &gt;= 37, and so no trimming was required. TRIBE edit details are listed for each experiment in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. The TRIBE data analysis was performed as described previously (<xref ref-type="bibr" rid="bib59">Rahman et al., 2018</xref>) with few modifications. The tools used for analysis are listed in Suppl. Table 6. Briefly, sequencing reads obtained were mapped to dm6 <italic>D. melanogaster</italic> genome using TopHat2 (<xref ref-type="bibr" rid="bib73">Trapnell et al., 2009</xref>) with the parameters ‘<monospace>--library-type</monospace> fr-firststrand -m 1 N 3 <monospace>--read-edit-dist</monospace> 3 p 5 g 2 -I 50000 <monospace>--microexon-search</monospace> <monospace>--no-coverage-search</monospace> -G dm6_genes.gtf’. Non-strand-specific sequencing reads were aligned using tophat2 with the parameters ‘-m 1 N 3 <monospace>--read-edit-dist</monospace> 3 p 5 g 2 -I 50000 <monospace>--microexon-search</monospace> <monospace>--no-coverage-search</monospace> -G dm6_genes.gtf’. The uniquely mapped SAM output file was loaded in the form of MySQL table with genomic coordinates. Edits for the brain samples were identified by comparing the nucleotide at each position of the genomic coordinates between experiment and control samples, and output was printed as bedgraph file. A threshold file was created by ensuring only edits with coverage of at least 20 reads and 15% edits were retained. This threshold file was used for all further analysis unless specified in the figure legends. All the TRIBE experiments were performed in duplicates, and only the edits identified in both the replicates above the edit threshold are reported.</p></sec><sec id="s4-10"><title>S2 cell TRIBE analysis</title><p>S2 cells were transfected with 500 ng of <italic>Act-Gal4</italic> and UAS-Atx2-ADAR plasmids (1:1). Cells were harvested 24 hr post transfection, and total RNA was extracted using TRIzol reagent (Invitrogen) as per the manufacturer’s protocol for NGS. Illumina libraries preparation and sequencing and TRIBE analysis were performed as described for fly brain samples. S2 cell genomic DNA sequence previously published by <xref ref-type="bibr" rid="bib47">McMahon et al., 2016</xref> was used as control to remove the background edits. S2 cell TRIBE was performed in triplicates, and the edits identified in all the replicates above the edit threshold are reported.</p></sec><sec id="s4-11"><title>Differential expression data analysis</title><p>RNA sequencing reads were mapped to dm6 <italic>D. melanogaster</italic> genome using STAR v2.5.3a with default parameters, and read counts were obtained using HTseq with ‘-s reverse’ parameter. DeSeq2 was used for differential expression analysis as described previously (<xref ref-type="bibr" rid="bib44">Love et al., 2014</xref>).</p></sec><sec id="s4-12"><title>Intron analysis</title><p>Nascent transcript analysis was performed by counting reads that emerged from intron sequences as described (<xref ref-type="bibr" rid="bib40">Lee et al., 2020</xref>). Briefly, FASTQ files were mapped to dm6 <italic>D. melanogaster</italic> genome using subjunc with default parameters in the Rsubread software package. Intron annotation SAF file was generated using the scripts found in <ext-link ext-link-type="uri" xlink:href="https://github.com/charitylaw/Intron-reads">https://github.com/charitylaw/Intron-reads</ext-link>; (<xref ref-type="bibr" rid="bib40">Lee et al., 2020</xref>). Featurecounts was used to count mapped reads to intron features. Read counts were normalized using DESeq2’s median of ratios.</p></sec><sec id="s4-13"><title>ARE analysis</title><p>ARE<italic>Score</italic> tool (<ext-link ext-link-type="uri" xlink:href="http://arescore.dkfz.de/arescore.pl">http://arescore.dkfz.de/arescore.pl</ext-link>) was used to perform ARE analysis. Only transcripts with 3′UTR &gt;10 nt in length were considered for analysis. mRNA with highest ARE<italic>Score</italic> was used when multiple transcript variants mapped to the same gene (isoforms of a gene).</p></sec><sec id="s4-14"><title>Motif analysis</title><p>The edit coordinates from the bed file were extended by 100 bp on either side using Bedtools slop. Intron-less sequences within this ± 100 bp were extracted using twoBitToFa. MEME suite was used to perform motif analysis on the generated FASTA sequences.</p></sec><sec id="s4-15"><title>Immunohistochemistry of adult <italic>Drosophila</italic> brains and S2 cells</title><p>Six-day-old adult fly brain was dissected in phosphate buffered saline (PBS) and fixed in PBS containing 4% paraformaldehyde (PFA) for 15 min at room temperature. The brains were then processed for immunostaining according to <xref ref-type="bibr" rid="bib70">Sudhakaran et al., 2014</xref>. Atx2 ADARcd was stained using rabbit anti-V5 antibody at 1:200 over one night at 4°C along with neuropil staining using mouse anti-Nc82 (1:100) (<xref ref-type="bibr" rid="bib33">Kittel, 2006</xref>). Secondary antibodies (1:1000) staining was done using anti-rabbit Alexa 488 and anti-mouse Alexa 555 (Molecular Probes) at room temperature for 2 hr. Stained brains were mounted in Vectashield Mounting Medium (Vector Laboratories) and imaged on a Zeiss LSM880 confocal microscope. S2 cells were prepared as described earlier (<xref ref-type="bibr" rid="bib6">Bakthavachalu et al., 2018</xref>). In brief, cells were fixed with 4% paraformaldehyde for 10 min at room temperature, followed by permeabilization with 0.05% Triton-X-100 for 10 min. This was followed by blocking with 1% bovine serum albumin (BSA) for 30 min. The cells were then stained with primary antibodies against Atx2 (1:500) or Rasputin (1:500), followed by probing with corresponding secondary antibodies conjugated with fluorophores. Confocal imaging was done using 60x/1.42 oil objective of Olympus FV3000 microscope. When proteins were SNAP-tagged, SNAP-Surface Alexa Fluor 546 was added after permeabilizing the cells. Confocal images were processed using CellProfiler (<ext-link ext-link-type="uri" xlink:href="https://cellprofiler.org/">https://cellprofiler.org/</ext-link>) to measure granules. At least 80 cells were included in each condition.</p></sec><sec id="s4-16"><title>Quantification and statistical analysis</title><p>The sample sizes are specified in the figures and figure legends of each experiments. The errors are represented as ± SEM with p-values (*p&lt;0.05, ****p&lt;0.0001) calculated by two-tailed Student’s t-test and Mann–Whitney test. Statistical analysis was performed in GraphPad Prism. Differential expression analysis by DEseq2 is reported for targets with p-value &lt;0.05.</p></sec><sec id="s4-17"><title>Contact for reagent and resource sharing</title><p>Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contacts Mani Ramaswami (<ext-link ext-link-type="uri" xlink:href="https://www.tcd.ie/research/profiles/?profile=ramaswam">mani.ramaswami@tcd.ie</ext-link>) and Baskar Bakthavachalu (<ext-link ext-link-type="uri" xlink:href="https://www.instem.res.in/tigs-ci/baskar-bakthavachalu">bbaskar@instem.res.in</ext-link>).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Roy Parker and members of the Ramaswami, VijayRaghavan, and Bakthavachalu labs for useful discussions and/or comments on the manuscript. Thanks to Michael Rosbash for <italic>Drosophila</italic> TRIBE plasmid and to colleagues acknowledged in the Key resources table for generously sharing essential reagents and informal advice. The fly facility at Bangalore Life Science Cluster (BLiSC) provided support with fly stock supply as well as generation of transgenic; CIFF at BLiSC provided essential confocal microscopy support; and Awadhesh Pandit and next-generation genomics facility at BLiSC provided NGS service. We acknowledge <italic>Drosophila</italic> Genomics Resource Centre (supported by NIH grant 2P40OC010949) for <italic>Drosophila</italic> S2 cells.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf3"><p>Reviewing editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf2"><p>Senior editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Validation, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Validation, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Validation, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Validation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con9"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con10"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Supervision, Funding acquisition, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Resources, Supervision, Funding acquisition, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Details of all the primers used in the study.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-60326-supp1-v1.docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>All the edits identified (without thresholding) in Targets of RNA-Binding Proteins Identified by Editing experiments are consolidated as a single spreadsheet file.</title><p>Each genotype is presented as a sheet within this file, and the raw and processed sequencing data is available at GEO accession number GSE153985.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60326-supp2-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-60326-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>The RNA Sequencing data has been deposited to GEO under the accession code GSE153985.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Kandi</surname><given-names>AR</given-names></name><name><surname>Ramaswami</surname><given-names>M</given-names></name><name><surname>Bakthavachalu</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensatation</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE153985">GSE153985</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Rosbash</surname><given-names>M</given-names></name><name><surname>McMahon</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>TRIBE: Hijacking an RNA-editing enzyme to identify cell-specific targets of RNA-binding proteins</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM2065948">GSM2065948</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilera-Gomez</surname> <given-names>A</given-names></name><name><surname>Zacharogianni</surname> <given-names>M</given-names></name><name><surname>van Oorschot</surname> <given-names>MM</given-names></name><name><surname>Genau</surname> <given-names>H</given-names></name><name><surname>Grond</surname> <given-names>R</given-names></name><name><surname>Veenendaal</surname> <given-names>T</given-names></name><name><surname>Sinsimer</surname> <given-names>KS</given-names></name><name><surname>Gavis</surname> <given-names>ER</given-names></name><name><surname>Behrends</surname> <given-names>C</given-names></name><name><surname>Rabouille</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Phospho-Rasputin stabilization by Sec16 is required for stress granule formation upon amino acid starvation</article-title><source>Cell Reports</source><volume>20</volume><elocation-id>2277</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2017.08.054</pub-id><pub-id pub-id-type="pmid">28746877</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albrecht</surname> <given-names>M</given-names></name><name><surname>Golatta</surname> <given-names>M</given-names></name><name><surname>Wüllner</surname> <given-names>U</given-names></name><name><surname>Lengauer</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Structural and functional analysis of ataxin-2 and ataxin-3</article-title><source>European Journal of Biochemistry</source><volume>271</volume><fpage>3155</fpage><lpage>3170</lpage><pub-id pub-id-type="doi">10.1111/j.1432-1033.2004.04245.x</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname> <given-names>S</given-names></name><name><surname>Pyl</surname> <given-names>PT</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HTSeq--a Python framework to work with high-throughput sequencing data</article-title><source>Bioinformatics</source><volume>31</volume><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arai</surname> <given-names>H</given-names></name><name><surname>Lee</surname> <given-names>VM</given-names></name><name><surname>Hill</surname> <given-names>WD</given-names></name><name><surname>Greenberg</surname> <given-names>BD</given-names></name><name><surname>Trojanowski</surname> <given-names>JQ</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Lewy bodies contain beta-amyloid precursor proteins of Alzheimer's disease</article-title><source>Brain Research</source><volume>585</volume><fpage>386</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(92)91242-7</pub-id><pub-id pub-id-type="pmid">1511324</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname> <given-names>TL</given-names></name><name><surname>Boden</surname> <given-names>M</given-names></name><name><surname>Buske</surname> <given-names>FA</given-names></name><name><surname>Frith</surname> <given-names>M</given-names></name><name><surname>Grant</surname> <given-names>CE</given-names></name><name><surname>Clementi</surname> <given-names>L</given-names></name><name><surname>Ren</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>WW</given-names></name><name><surname>Noble</surname> <given-names>WS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>MEME SUITE: tools for motif discovery and searching</article-title><source>Nucleic Acids Research</source><volume>37</volume><fpage>W202</fpage><lpage>W208</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp335</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakthavachalu</surname> <given-names>B</given-names></name><name><surname>Huelsmeier</surname> <given-names>J</given-names></name><name><surname>Sudhakaran</surname> <given-names>IP</given-names></name><name><surname>Hillebrand</surname> <given-names>J</given-names></name><name><surname>Singh</surname> <given-names>A</given-names></name><name><surname>Petrauskas</surname> <given-names>A</given-names></name><name><surname>Thiagarajan</surname> <given-names>D</given-names></name><name><surname>Sankaranarayanan</surname> <given-names>M</given-names></name><name><surname>Mizoue</surname> <given-names>L</given-names></name><name><surname>Anderson</surname> <given-names>EN</given-names></name><name><surname>Pandey</surname> <given-names>UB</given-names></name><name><surname>Ross</surname> <given-names>E</given-names></name><name><surname>VijayRaghavan</surname> <given-names>K</given-names></name><name><surname>Parker</surname> <given-names>R</given-names></name><name><surname>Ramaswami</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>RNP-Granule assembly via Ataxin-2 disordered domains is required for Long-Term memory and neurodegeneration</article-title><source>Neuron</source><volume>98</volume><fpage>754</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.04.032</pub-id><pub-id pub-id-type="pmid">29772202</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname> <given-names>LA</given-names></name><name><surname>Huang</surname> <given-names>B</given-names></name><name><surname>Bieri</surname> <given-names>G</given-names></name><name><surname>Ma</surname> <given-names>R</given-names></name><name><surname>Knowles</surname> <given-names>DA</given-names></name><name><surname>Jafar-Nejad</surname> <given-names>P</given-names></name><name><surname>Messing</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>HJ</given-names></name><name><surname>Soriano</surname> <given-names>A</given-names></name><name><surname>Auburger</surname> <given-names>G</given-names></name><name><surname>Pulst</surname> <given-names>SM</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name><name><surname>Rigo</surname> <given-names>F</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice</article-title><source>Nature</source><volume>544</volume><fpage>367</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1038/nature22038</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname> <given-names>LA</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ataxin-2 is droppin' Some knowledge</article-title><source>Neuron</source><volume>98</volume><fpage>673</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.05.002</pub-id><pub-id pub-id-type="pmid">29772196</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bentmann</surname> <given-names>E</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name><name><surname>Dormann</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma</article-title><source>FEBS Journal</source><volume>280</volume><fpage>4348</fpage><lpage>4370</lpage><pub-id pub-id-type="doi">10.1111/febs.12287</pub-id><pub-id pub-id-type="pmid">23587065</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname> <given-names>J</given-names></name><name><surname>Rahman</surname> <given-names>R</given-names></name><name><surname>Gupta</surname> <given-names>V</given-names></name><name><surname>Rosbash</surname> <given-names>M</given-names></name><name><surname>Singer</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>MS2-TRIBE evaluates both Protein-RNA interactions and nuclear organization of transcription by RNA editing</article-title><source>iScience</source><volume>23</volume><elocation-id>101318</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2020.101318</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonenfant</surname> <given-names>G</given-names></name><name><surname>Williams</surname> <given-names>N</given-names></name><name><surname>Netzband</surname> <given-names>R</given-names></name><name><surname>Schwarz</surname> <given-names>MC</given-names></name><name><surname>Evans</surname> <given-names>MJ</given-names></name><name><surname>Pager</surname> <given-names>CT</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Zika virus subverts stress granules to promote and restrict viral gene expression</article-title><source>Journal of Virology</source><volume>93</volume><elocation-id>e00520-19</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.00520-19</pub-id><pub-id pub-id-type="pmid">30944179</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brettschneider</surname> <given-names>J</given-names></name><name><surname>Del Tredici</surname> <given-names>K</given-names></name><name><surname>Lee</surname> <given-names>VM</given-names></name><name><surname>Trojanowski</surname> <given-names>JQ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Spreading of pathology in neurodegenerative diseases: a focus on human studies</article-title><source>Nature Reviews Neuroscience</source><volume>16</volume><fpage>109</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1038/nrn3887</pub-id><pub-id pub-id-type="pmid">25588378</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calabretta</surname> <given-names>S</given-names></name><name><surname>Richard</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Emerging roles of disordered sequences in RNA-Binding proteins</article-title><source>Trends in Biochemical Sciences</source><volume>40</volume><fpage>662</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2015.08.012</pub-id><pub-id pub-id-type="pmid">26481498</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciosk</surname> <given-names>R</given-names></name><name><surname>DePalma</surname> <given-names>M</given-names></name><name><surname>Priess</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>ATX-2, the <italic>C. elegans</italic> ortholog of ataxin 2, functions in translational regulation in the germline</article-title><source>Development</source><volume>131</volume><fpage>4831</fpage><lpage>4841</lpage><pub-id pub-id-type="doi">10.1242/dev.01352</pub-id><pub-id pub-id-type="pmid">15342467</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courchaine</surname> <given-names>EM</given-names></name><name><surname>Lu</surname> <given-names>A</given-names></name><name><surname>Neugebauer</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Droplet organelles?</article-title><source>The EMBO Journal</source><volume>35</volume><fpage>1603</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.15252/embj.201593517</pub-id><pub-id pub-id-type="pmid">27357569</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname> <given-names>X</given-names></name><name><surname>Wei</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Sun</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>S-W</given-names></name><name><surname>Huang</surname> <given-names>Y</given-names></name><name><surname>Meng</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Guitar: an R/Bioconductor package for gene annotation guided transcriptomic analysis of RNA-Related genomic features</article-title><source>BioMed Research International</source><volume>2016</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1155/2016/8367534</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dansithong</surname> <given-names>W</given-names></name><name><surname>Paul</surname> <given-names>S</given-names></name><name><surname>Figueroa</surname> <given-names>KP</given-names></name><name><surname>Rinehart</surname> <given-names>MD</given-names></name><name><surname>Wiest</surname> <given-names>S</given-names></name><name><surname>Pflieger</surname> <given-names>LT</given-names></name><name><surname>Scoles</surname> <given-names>DR</given-names></name><name><surname>Pulst</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ataxin-2 regulates RGS8 translation in a new BAC-SCA2 transgenic mouse model</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1005182</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005182</pub-id><pub-id pub-id-type="pmid">25902068</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daoud</surname> <given-names>H</given-names></name><name><surname>Belzil</surname> <given-names>V</given-names></name><name><surname>Martins</surname> <given-names>S</given-names></name><name><surname>Sabbagh</surname> <given-names>M</given-names></name><name><surname>Provencher</surname> <given-names>P</given-names></name><name><surname>Lacomblez</surname> <given-names>L</given-names></name><name><surname>Meininger</surname> <given-names>V</given-names></name><name><surname>Camu</surname> <given-names>W</given-names></name><name><surname>Dupré</surname> <given-names>N</given-names></name><name><surname>Dion</surname> <given-names>PA</given-names></name><name><surname>Rouleau</surname> <given-names>GA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis</article-title><source>Archives of Neurology</source><volume>68</volume><fpage>739</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1001/archneurol.2011.111</pub-id><pub-id pub-id-type="pmid">21670397</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Castillo</surname> <given-names>U</given-names></name><name><surname>Gnazzo</surname> <given-names>MM</given-names></name><name><surname>Sorensen Turpin</surname> <given-names>CG</given-names></name><name><surname>Nguyen</surname> <given-names>KCQ</given-names></name><name><surname>Semaya</surname> <given-names>E</given-names></name><name><surname>Lam</surname> <given-names>Y</given-names></name><name><surname>de Cruz</surname> <given-names>MA</given-names></name><name><surname>Bembenek</surname> <given-names>JN</given-names></name><name><surname>Hall</surname> <given-names>DH</given-names></name><name><surname>Riggs</surname> <given-names>B</given-names></name><name><surname>Gelfand</surname> <given-names>VI</given-names></name><name><surname>Skop</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Conserved role for Ataxin-2 in mediating endoplasmic reticulum dynamics</article-title><source>Traffic</source><volume>20</volume><fpage>436</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1111/tra.12647</pub-id><pub-id pub-id-type="pmid">30989774</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Schlesinger</surname> <given-names>F</given-names></name><name><surname>Drenkow</surname> <given-names>J</given-names></name><name><surname>Zaleski</surname> <given-names>C</given-names></name><name><surname>Jha</surname> <given-names>S</given-names></name><name><surname>Batut</surname> <given-names>P</given-names></name><name><surname>Chaisson</surname> <given-names>M</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elden</surname> <given-names>AC</given-names></name><name><surname>Kim</surname> <given-names>HJ</given-names></name><name><surname>Hart</surname> <given-names>MP</given-names></name><name><surname>Chen-Plotkin</surname> <given-names>AS</given-names></name><name><surname>Johnson</surname> <given-names>BS</given-names></name><name><surname>Fang</surname> <given-names>X</given-names></name><name><surname>Armakola</surname> <given-names>M</given-names></name><name><surname>Geser</surname> <given-names>F</given-names></name><name><surname>Greene</surname> <given-names>R</given-names></name><name><surname>Lu</surname> <given-names>MM</given-names></name><name><surname>Padmanabhan</surname> <given-names>A</given-names></name><name><surname>Clay-Falcone</surname> <given-names>D</given-names></name><name><surname>McCluskey</surname> <given-names>L</given-names></name><name><surname>Elman</surname> <given-names>L</given-names></name><name><surname>Juhr</surname> <given-names>D</given-names></name><name><surname>Gruber</surname> <given-names>PJ</given-names></name><name><surname>Rüb</surname> <given-names>U</given-names></name><name><surname>Auburger</surname> <given-names>G</given-names></name><name><surname>Trojanowski</surname> <given-names>JQ</given-names></name><name><surname>Lee</surname> <given-names>VM</given-names></name><name><surname>Van Deerlin</surname> <given-names>VM</given-names></name><name><surname>Bonini</surname> <given-names>NM</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS</article-title><source>Nature</source><volume>466</volume><fpage>1069</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1038/nature09320</pub-id><pub-id pub-id-type="pmid">20740007</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emery</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Protein extraction <italic>from Drosophila</italic> heads</article-title><source>Methods in Molecular Biology</source><volume>362</volume><fpage>375</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1007/978-1-59745-257-1_27</pub-id><pub-id pub-id-type="pmid">17417024</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Mauriño</surname> <given-names>SM</given-names></name><name><surname>Rivero-Rodríguez</surname> <given-names>F</given-names></name><name><surname>Velázquez-Cruz</surname> <given-names>A</given-names></name><name><surname>Hernández-Vellisca</surname> <given-names>M</given-names></name><name><surname>Díaz-Quintana</surname> <given-names>A</given-names></name><name><surname>De la Rosa</surname> <given-names>MA</given-names></name><name><surname>Díaz-Moreno</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RNA binding protein regulation and Cross-Talk in the control of AU-rich mRNA fate</article-title><source>Frontiers in Molecular Biosciences</source><volume>4</volume><elocation-id>71</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2017.00071</pub-id><pub-id pub-id-type="pmid">29109951</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillén-Boixet</surname> <given-names>J</given-names></name><name><surname>Kopach</surname> <given-names>A</given-names></name><name><surname>Holehouse</surname> <given-names>AS</given-names></name><name><surname>Wittmann</surname> <given-names>S</given-names></name><name><surname>Jahnel</surname> <given-names>M</given-names></name><name><surname>Schlüßler</surname> <given-names>R</given-names></name><name><surname>Kim</surname> <given-names>K</given-names></name><name><surname>Trussina</surname> <given-names>I</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Mateju</surname> <given-names>D</given-names></name><name><surname>Poser</surname> <given-names>I</given-names></name><name><surname>Maharana</surname> <given-names>S</given-names></name><name><surname>Ruer-Gruß</surname> <given-names>M</given-names></name><name><surname>Richter</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Chang</surname> <given-names>YT</given-names></name><name><surname>Guck</surname> <given-names>J</given-names></name><name><surname>Honigmann</surname> <given-names>A</given-names></name><name><surname>Mahamid</surname> <given-names>J</given-names></name><name><surname>Hyman</surname> <given-names>AA</given-names></name><name><surname>Pappu</surname> <given-names>RV</given-names></name><name><surname>Alberti</surname> <given-names>S</given-names></name><name><surname>Franzmann</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>RNA-Induced conformational switching and clustering of G3BP drive stress granule assembly by condensation</article-title><source>Cell</source><volume>181</volume><fpage>346</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.03.049</pub-id><pub-id pub-id-type="pmid">32302572</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halbach</surname> <given-names>MV</given-names></name><name><surname>Gispert</surname> <given-names>S</given-names></name><name><surname>Stehning</surname> <given-names>T</given-names></name><name><surname>Damrath</surname> <given-names>E</given-names></name><name><surname>Walter</surname> <given-names>M</given-names></name><name><surname>Auburger</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Atxn2 knockout and CAG42-Knock-in cerebellum shows similarly dysregulated expression in calcium homeostasis pathway</article-title><source>The Cerebellum</source><volume>16</volume><fpage>68</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1007/s12311-016-0762-4</pub-id><pub-id pub-id-type="pmid">26868665</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hentze</surname> <given-names>MW</given-names></name><name><surname>Castello</surname> <given-names>A</given-names></name><name><surname>Schwarzl</surname> <given-names>T</given-names></name><name><surname>Preiss</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A brave new world of RNA-binding proteins</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>19</volume><fpage>327</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.130</pub-id><pub-id pub-id-type="pmid">29339797</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inagaki</surname> <given-names>H</given-names></name><name><surname>Hosoda</surname> <given-names>N</given-names></name><name><surname>Tsuiji</surname> <given-names>H</given-names></name><name><surname>Hoshino</surname> <given-names>SI</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Direct evidence that Ataxin-2 is a translational activator mediating cytoplasmic polyadenylation</article-title><source>Journal of Biological Chemistry</source><volume>295</volume><fpage>15810</fpage><lpage>15825</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA120.013835</pub-id><pub-id pub-id-type="pmid">32989052</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname> <given-names>A</given-names></name><name><surname>Vale</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RNA phase transitions in repeat expansion disorders</article-title><source>Nature</source><volume>546</volume><fpage>243</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1038/nature22386</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>H</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Rahman</surname> <given-names>R</given-names></name><name><surname>Na</surname> <given-names>D</given-names></name><name><surname>Fieldsend</surname> <given-names>A</given-names></name><name><surname>Song</surname> <given-names>W</given-names></name><name><surname>Liu</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Rosbash</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>TRIBE editing reveals specific mRNA targets of eIF4E-BP in <italic>Drosophila</italic> and in mammals</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eabb8771</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abb8771</pub-id><pub-id pub-id-type="pmid">32851185</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Han</surname> <given-names>TW</given-names></name><name><surname>Xie</surname> <given-names>S</given-names></name><name><surname>Shi</surname> <given-names>K</given-names></name><name><surname>Du</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>LC</given-names></name><name><surname>Mirzaei</surname> <given-names>H</given-names></name><name><surname>Goldsmith</surname> <given-names>EJ</given-names></name><name><surname>Longgood</surname> <given-names>J</given-names></name><name><surname>Pei</surname> <given-names>J</given-names></name><name><surname>Grishin</surname> <given-names>NV</given-names></name><name><surname>Frantz</surname> <given-names>DE</given-names></name><name><surname>Schneider</surname> <given-names>JW</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Sawaya</surname> <given-names>MR</given-names></name><name><surname>Eisenberg</surname> <given-names>D</given-names></name><name><surname>Tycko</surname> <given-names>R</given-names></name><name><surname>McKnight</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels</article-title><source>Cell</source><volume>149</volume><fpage>753</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.04.017</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Yang</surname> <given-names>YS</given-names></name><name><surname>Sutter</surname> <given-names>BM</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>McKnight</surname> <given-names>SL</given-names></name><name><surname>Tu</surname> <given-names>BP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Redox state controls phase separation of the yeast Ataxin-2 protein via reversible oxidation of its Methionine-Rich Low-Complexity domain</article-title><source>Cell</source><volume>177</volume><fpage>711</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.02.044</pub-id><pub-id pub-id-type="pmid">30982603</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>McKnight</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A Solid-State conceptualization of information transfer from gene to message to protein</article-title><source>Annual Review of Biochemistry</source><volume>87</volume><fpage>351</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-061516-044700</pub-id><pub-id pub-id-type="pmid">29195049</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittel</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Bruchpilot promotes active zone assembly, Ca2+ channel clustering, and vesicle release</article-title><source>Science</source><volume>312</volume><fpage>1051</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1126/science.1126308</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lastres-Becker</surname> <given-names>I</given-names></name><name><surname>Rüb</surname> <given-names>U</given-names></name><name><surname>Auburger</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Spinocerebellar ataxia 2 (SCA2)</article-title><source>The Cerebellum</source><volume>7</volume><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1007/s12311-008-0019-y</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lastres-Becker</surname> <given-names>I</given-names></name><name><surname>Nonis</surname> <given-names>D</given-names></name><name><surname>Eich</surname> <given-names>F</given-names></name><name><surname>Klinkenberg</surname> <given-names>M</given-names></name><name><surname>Gorospe</surname> <given-names>M</given-names></name><name><surname>Kötter</surname> <given-names>P</given-names></name><name><surname>Klein</surname> <given-names>FAC</given-names></name><name><surname>Kedersha</surname> <given-names>N</given-names></name><name><surname>Auburger</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mammalian ataxin-2 modulates translation control at the pre-initiation complex via PI3K/mTOR and is induced by starvation</article-title><source>Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease</source><volume>1862</volume><fpage>1558</fpage><lpage>1569</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2016.05.017</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laver</surname> <given-names>JD</given-names></name><name><surname>Ly</surname> <given-names>J</given-names></name><name><surname>Winn</surname> <given-names>AK</given-names></name><name><surname>Karaiskakis</surname> <given-names>A</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name><name><surname>Nie</surname> <given-names>K</given-names></name><name><surname>Benic</surname> <given-names>G</given-names></name><name><surname>Jaberi-Lashkari</surname> <given-names>N</given-names></name><name><surname>Cao</surname> <given-names>WX</given-names></name><name><surname>Khademi</surname> <given-names>A</given-names></name><name><surname>Westwood</surname> <given-names>JT</given-names></name><name><surname>Sidhu</surname> <given-names>SS</given-names></name><name><surname>Morris</surname> <given-names>Q</given-names></name><name><surname>Angers</surname> <given-names>S</given-names></name><name><surname>Smibert</surname> <given-names>CA</given-names></name><name><surname>Lipshitz</surname> <given-names>HD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The RNA-Binding protein rasputin/G3BP enhances the stability and translation of its target mRNAs</article-title><source>Cell Reports</source><volume>30</volume><fpage>3353</fpage><lpage>3367</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.02.066</pub-id><pub-id pub-id-type="pmid">32160542</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>VM</given-names></name><name><surname>Balin</surname> <given-names>BJ</given-names></name><name><surname>Otvos</surname> <given-names>L</given-names></name><name><surname>Trojanowski</surname> <given-names>JQ</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>A68: a major subunit of paired helical filaments and derivatized forms of normal tau</article-title><source>Science</source><volume>251</volume><fpage>675</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1126/science.1899488</pub-id><pub-id pub-id-type="pmid">1899488</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>T</given-names></name><name><surname>Li</surname> <given-names>YR</given-names></name><name><surname>Ingre</surname> <given-names>C</given-names></name><name><surname>Weber</surname> <given-names>M</given-names></name><name><surname>Grehl</surname> <given-names>T</given-names></name><name><surname>Gredal</surname> <given-names>O</given-names></name><name><surname>de Carvalho</surname> <given-names>M</given-names></name><name><surname>Meyer</surname> <given-names>T</given-names></name><name><surname>Tysnes</surname> <given-names>OB</given-names></name><name><surname>Auburger</surname> <given-names>G</given-names></name><name><surname>Gispert</surname> <given-names>S</given-names></name><name><surname>Bonini</surname> <given-names>NM</given-names></name><name><surname>Andersen</surname> <given-names>PM</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Ataxin-2 intermediate-length polyglutamine expansions in european ALS patients</article-title><source>Human Molecular Genetics</source><volume>20</volume><fpage>1697</fpage><lpage>1700</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddr045</pub-id><pub-id pub-id-type="pmid">21292779</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Yoo</surname> <given-names>E</given-names></name><name><surname>Lee</surname> <given-names>H</given-names></name><name><surname>Park</surname> <given-names>K</given-names></name><name><surname>Hur</surname> <given-names>JH</given-names></name><name><surname>Lim</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>LSM12 and ME31B/DDX6 define distinct modes of posttranscriptional regulation by ATAXIN-2 protein complex in <italic>Drosophila</italic> circadian pacemaker neurons</article-title><source>Molecular Cell</source><volume>66</volume><fpage>129</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.03.004</pub-id><pub-id pub-id-type="pmid">28388438</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>AY</given-names></name><name><surname>Su</surname> <given-names>S</given-names></name><name><surname>Ng</surname> <given-names>AP</given-names></name><name><surname>Holik</surname> <given-names>AZ</given-names></name><name><surname>Asselin-Labat</surname> <given-names>M-L</given-names></name><name><surname>Ritchie</surname> <given-names>ME</given-names></name><name><surname>Law</surname> <given-names>CW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Covering all your bases: incorporating intron signal from RNA-seq data</article-title><source>NAR Genomics and Bioinformatics</source><volume>2</volume><elocation-id>lqaa073</elocation-id><pub-id pub-id-type="doi">10.1093/nargab/lqaa073</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>YR</given-names></name><name><surname>King</surname> <given-names>OD</given-names></name><name><surname>Shorter</surname> <given-names>J</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Stress granules as crucibles of ALS pathogenesis</article-title><source>The Journal of Cell Biology</source><volume>201</volume><fpage>361</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1083/jcb.201302044</pub-id><pub-id pub-id-type="pmid">23629963</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname> <given-names>C</given-names></name><name><surname>Allada</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>ATAXIN-2 activates PERIOD translation to sustain circadian rhythms in <italic>Drosophila</italic></article-title><source>Science</source><volume>340</volume><fpage>875</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1126/science.1234785</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López de Silanes</surname> <given-names>I</given-names></name><name><surname>Zhan</surname> <given-names>M</given-names></name><name><surname>Lal</surname> <given-names>A</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Gorospe</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Identification of a target RNA motif for RNA-binding protein HuR</article-title><source>PNAS</source><volume>101</volume><fpage>2987</fpage><lpage>2992</lpage><pub-id pub-id-type="doi">10.1073/pnas.0306453101</pub-id><pub-id pub-id-type="pmid">14981256</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayya</surname> <given-names>VK</given-names></name><name><surname>Duchaine</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ciphers and executioners: how 3'-Untranslated regions determine the fate of messenger RNAs</article-title><source>Frontiers in Genetics</source><volume>10</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2019.00006</pub-id><pub-id pub-id-type="pmid">30740123</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCann</surname> <given-names>C</given-names></name><name><surname>Holohan</surname> <given-names>EE</given-names></name><name><surname>Das</surname> <given-names>S</given-names></name><name><surname>Dervan</surname> <given-names>A</given-names></name><name><surname>Larkin</surname> <given-names>A</given-names></name><name><surname>Lee</surname> <given-names>JA</given-names></name><name><surname>Rodrigues</surname> <given-names>V</given-names></name><name><surname>Parker</surname> <given-names>R</given-names></name><name><surname>Ramaswami</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The Ataxin-2 protein is required for microRNA function and synapse-specific long-term olfactory habituation</article-title><source>PNAS</source><volume>108</volume><fpage>E655</fpage><lpage>E662</lpage><pub-id pub-id-type="doi">10.1073/pnas.1107198108</pub-id><pub-id pub-id-type="pmid">21795609</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname> <given-names>AC</given-names></name><name><surname>Rahman</surname> <given-names>R</given-names></name><name><surname>Jin</surname> <given-names>H</given-names></name><name><surname>Shen</surname> <given-names>JL</given-names></name><name><surname>Fieldsend</surname> <given-names>A</given-names></name><name><surname>Luo</surname> <given-names>W</given-names></name><name><surname>Rosbash</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>TRIBE: hijacking an RNA-Editing enzyme to identify Cell-Specific targets of RNA-Binding proteins</article-title><source>Cell</source><volume>165</volume><fpage>742</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.03.007</pub-id><pub-id pub-id-type="pmid">27040499</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McQuin</surname> <given-names>C</given-names></name><name><surname>Goodman</surname> <given-names>A</given-names></name><name><surname>Chernyshev</surname> <given-names>V</given-names></name><name><surname>Kamentsky</surname> <given-names>L</given-names></name><name><surname>Cimini</surname> <given-names>BA</given-names></name><name><surname>Karhohs</surname> <given-names>KW</given-names></name><name><surname>Doan</surname> <given-names>M</given-names></name><name><surname>Ding</surname> <given-names>L</given-names></name><name><surname>Rafelski</surname> <given-names>SM</given-names></name><name><surname>Thirstrup</surname> <given-names>D</given-names></name><name><surname>Wiegraebe</surname> <given-names>W</given-names></name><name><surname>Singh</surname> <given-names>S</given-names></name><name><surname>Becker</surname> <given-names>T</given-names></name><name><surname>Caicedo</surname> <given-names>JC</given-names></name><name><surname>Carpenter</surname> <given-names>AE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CellProfiler 3.0: next-generation image processing for biology</article-title><source>PLOS Biology</source><volume>16</volume><elocation-id>e2005970</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.2005970</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meierhofer</surname> <given-names>D</given-names></name><name><surname>Halbach</surname> <given-names>M</given-names></name><name><surname>Şen</surname> <given-names>NE</given-names></name><name><surname>Gispert</surname> <given-names>S</given-names></name><name><surname>Auburger</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ataxin-2 (Atxn2)-Knock-Out mice show branched chain amino acids and fatty acids pathway alterations</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>15</volume><fpage>1728</fpage><lpage>1739</lpage><pub-id pub-id-type="doi">10.1074/mcp.M115.056770</pub-id><pub-id pub-id-type="pmid">26850065</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname> <given-names>P</given-names></name><name><surname>Shenker</surname> <given-names>S</given-names></name><name><surname>Andreu-Agullo</surname> <given-names>C</given-names></name><name><surname>Westholm</surname> <given-names>JO</given-names></name><name><surname>Lai</surname> <given-names>EC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Widespread and extensive lengthening of 3' UTRs in the mammalian brain</article-title><source>Genome Research</source><volume>23</volume><fpage>812</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1101/gr.146886.112</pub-id><pub-id pub-id-type="pmid">23520388</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>DT</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Thurber</surname> <given-names>KR</given-names></name><name><surname>Hung</surname> <given-names>I</given-names></name><name><surname>McKnight</surname> <given-names>SL</given-names></name><name><surname>Tycko</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Structure of FUS protein fibrils and its relevance to Self-Assembly and phase separation of Low-Complexity domains</article-title><source>Cell</source><volume>171</volume><fpage>615</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.08.048</pub-id><pub-id pub-id-type="pmid">28942918</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nedelsky</surname> <given-names>NB</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Bridging biophysics and neurology: aberrant phase transitions in neurodegenerative disease</article-title><source>Nature Reviews Neurology</source><volume>15</volume><fpage>272</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1038/s41582-019-0157-5</pub-id><pub-id pub-id-type="pmid">30890779</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nonhoff</surname> <given-names>U</given-names></name><name><surname>Ralser</surname> <given-names>M</given-names></name><name><surname>Welzel</surname> <given-names>F</given-names></name><name><surname>Piccini</surname> <given-names>I</given-names></name><name><surname>Balzereit</surname> <given-names>D</given-names></name><name><surname>Yaspo</surname> <given-names>ML</given-names></name><name><surname>Lehrach</surname> <given-names>H</given-names></name><name><surname>Krobitsch</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules</article-title><source>Molecular Biology of the Cell</source><volume>18</volume><fpage>1385</fpage><lpage>1396</lpage><pub-id pub-id-type="doi">10.1091/mbc.e06-12-1120</pub-id><pub-id pub-id-type="pmid">17392519</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otsuka</surname> <given-names>H</given-names></name><name><surname>Fukao</surname> <given-names>A</given-names></name><name><surname>Funakami</surname> <given-names>Y</given-names></name><name><surname>Duncan</surname> <given-names>KE</given-names></name><name><surname>Fujiwara</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Emerging evidence of translational control by AU-Rich Element-Binding proteins</article-title><source>Frontiers in Genetics</source><volume>10</volume><elocation-id>332</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2019.00332</pub-id><pub-id pub-id-type="pmid">31118942</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname> <given-names>A</given-names></name><name><surname>Lee</surname> <given-names>HO</given-names></name><name><surname>Jawerth</surname> <given-names>L</given-names></name><name><surname>Maharana</surname> <given-names>S</given-names></name><name><surname>Jahnel</surname> <given-names>M</given-names></name><name><surname>Hein</surname> <given-names>MY</given-names></name><name><surname>Stoynov</surname> <given-names>S</given-names></name><name><surname>Mahamid</surname> <given-names>J</given-names></name><name><surname>Saha</surname> <given-names>S</given-names></name><name><surname>Franzmann</surname> <given-names>TM</given-names></name><name><surname>Pozniakovski</surname> <given-names>A</given-names></name><name><surname>Poser</surname> <given-names>I</given-names></name><name><surname>Maghelli</surname> <given-names>N</given-names></name><name><surname>Royer</surname> <given-names>LA</given-names></name><name><surname>Weigert</surname> <given-names>M</given-names></name><name><surname>Myers</surname> <given-names>EW</given-names></name><name><surname>Grill</surname> <given-names>S</given-names></name><name><surname>Drechsel</surname> <given-names>D</given-names></name><name><surname>Hyman</surname> <given-names>AA</given-names></name><name><surname>Alberti</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A Liquid-to-Solid phase transition of the ALS protein FUS accelerated by disease mutation</article-title><source>Cell</source><volume>162</volume><fpage>1066</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.07.047</pub-id><pub-id pub-id-type="pmid">26317470</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>SS</given-names></name><name><surname>Chen</surname> <given-names>CY</given-names></name><name><surname>Xu</surname> <given-names>N</given-names></name><name><surname>Shyu</surname> <given-names>AB</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein</article-title><source>The EMBO Journal</source><volume>17</volume><fpage>3461</fpage><lpage>3470</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.12.3461</pub-id><pub-id pub-id-type="pmid">9628881</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeffer</surname> <given-names>M</given-names></name><name><surname>Gispert</surname> <given-names>S</given-names></name><name><surname>Auburger</surname> <given-names>G</given-names></name><name><surname>Wicht</surname> <given-names>H</given-names></name><name><surname>Korf</surname> <given-names>HW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Impact of Ataxin-2 knock out on circadian locomotor behavior and PER immunoreaction in the SCN of mice</article-title><source>Chronobiology International</source><volume>34</volume><fpage>129</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1080/07420528.2016.1245666</pub-id><pub-id pub-id-type="pmid">27791392</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname> <given-names>AR</given-names></name><name><surname>Hall</surname> <given-names>IM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title><source>Bioinformatics</source><volume>26</volume><fpage>841</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id><pub-id pub-id-type="pmid">20110278</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname> <given-names>R</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Jin</surname> <given-names>H</given-names></name><name><surname>Rosbash</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Identification of RNA-binding protein targets with HyperTRIBE</article-title><source>Nature Protocols</source><volume>13</volume><fpage>1829</fpage><lpage>1849</lpage><pub-id pub-id-type="doi">10.1038/s41596-018-0020-y</pub-id><pub-id pub-id-type="pmid">30013039</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ralser</surname> <given-names>M</given-names></name><name><surname>Albrecht</surname> <given-names>M</given-names></name><name><surname>Nonhoff</surname> <given-names>U</given-names></name><name><surname>Lengauer</surname> <given-names>T</given-names></name><name><surname>Lehrach</surname> <given-names>H</given-names></name><name><surname>Krobitsch</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>An integrative approach to gain insights into the cellular function of human ataxin-2</article-title><source>Journal of Molecular Biology</source><volume>346</volume><fpage>203</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2004.11.024</pub-id><pub-id pub-id-type="pmid">15663938</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramaswami</surname> <given-names>M</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name><name><surname>Parker</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Altered ribostasis: rna-protein granules in degenerative disorders</article-title><source>Cell</source><volume>154</volume><fpage>727</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.07.038</pub-id><pub-id pub-id-type="pmid">23953108</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saha</surname> <given-names>S</given-names></name><name><surname>Hyman</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RNA gets in phase</article-title><source>Journal of Cell Biology</source><volume>216</volume><fpage>2235</fpage><lpage>2237</lpage><pub-id pub-id-type="doi">10.1083/jcb.201706034</pub-id><pub-id pub-id-type="pmid">28667121</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname> <given-names>DW</given-names></name><name><surname>Kedersha</surname> <given-names>N</given-names></name><name><surname>Lee</surname> <given-names>DSW</given-names></name><name><surname>Strom</surname> <given-names>AR</given-names></name><name><surname>Drake</surname> <given-names>V</given-names></name><name><surname>Riback</surname> <given-names>JA</given-names></name><name><surname>Bracha</surname> <given-names>D</given-names></name><name><surname>Eeftens</surname> <given-names>JM</given-names></name><name><surname>Iwanicki</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>A</given-names></name><name><surname>Wei</surname> <given-names>M-T</given-names></name><name><surname>Whitney</surname> <given-names>G</given-names></name><name><surname>Lyons</surname> <given-names>SM</given-names></name><name><surname>Anderson</surname> <given-names>P</given-names></name><name><surname>Jacobs</surname> <given-names>WM</given-names></name><name><surname>Ivanov</surname> <given-names>P</given-names></name><name><surname>Brangwynne</surname> <given-names>CP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Competing Protein-RNA interaction networks control multiphase intracellular organization</article-title><source>Cell</source><volume>181</volume><fpage>306</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.03.050</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satterfield</surname> <given-names>TF</given-names></name><name><surname>Pallanck</surname> <given-names>LJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ataxin-2 and its <italic>Drosophila</italic> homolog, ATX2, physically assemble with polyribosomes</article-title><source>Human Molecular Genetics</source><volume>15</volume><fpage>2523</fpage><lpage>2532</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddl173</pub-id><pub-id pub-id-type="pmid">16835262</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname> <given-names>CA</given-names></name><name><surname>Rasband</surname> <given-names>WS</given-names></name><name><surname>Eliceiri</surname> <given-names>KW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NIH image to ImageJ: 25 years of image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>671</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2089</pub-id><pub-id pub-id-type="pmid">22930834</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scoles</surname> <given-names>DR</given-names></name><name><surname>Meera</surname> <given-names>P</given-names></name><name><surname>Schneider</surname> <given-names>MD</given-names></name><name><surname>Paul</surname> <given-names>S</given-names></name><name><surname>Dansithong</surname> <given-names>W</given-names></name><name><surname>Figueroa</surname> <given-names>KP</given-names></name><name><surname>Hung</surname> <given-names>G</given-names></name><name><surname>Rigo</surname> <given-names>F</given-names></name><name><surname>Bennett</surname> <given-names>CF</given-names></name><name><surname>Otis</surname> <given-names>TS</given-names></name><name><surname>Pulst</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Antisense oligonucleotide therapy for spinocerebellar ataxia type 2</article-title><source>Nature</source><volume>544</volume><fpage>362</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1038/nature22044</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scoles</surname> <given-names>DR</given-names></name><name><surname>Pulst</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Spinocerebellar ataxia type 2advances in experimental medicine and biology</article-title><source>Nature Reviews. Neurology</source><volume>14</volume><fpage>590</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1038/s41582-018-0051-6</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname> <given-names>N-E</given-names></name><name><surname>Arsovic</surname> <given-names>A</given-names></name><name><surname>Meierhofer</surname> <given-names>D</given-names></name><name><surname>Brodesser</surname> <given-names>S</given-names></name><name><surname>Oberschmidt</surname> <given-names>C</given-names></name><name><surname>Canet-Pons</surname> <given-names>J</given-names></name><name><surname>Kaya</surname> <given-names>Z-E</given-names></name><name><surname>Halbach</surname> <given-names>M-V</given-names></name><name><surname>Gispert</surname> <given-names>S</given-names></name><name><surname>Sandhoff</surname> <given-names>K</given-names></name><name><surname>Auburger</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>In human and mouse Spino-Cerebellar tissue, Ataxin-2 expansion affects Ceramide-Sphingomyelin metabolism</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><elocation-id>5854</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20235854</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spasic</surname> <given-names>M</given-names></name><name><surname>Friedel</surname> <given-names>CC</given-names></name><name><surname>Schott</surname> <given-names>J</given-names></name><name><surname>Kreth</surname> <given-names>J</given-names></name><name><surname>Leppek</surname> <given-names>K</given-names></name><name><surname>Hofmann</surname> <given-names>S</given-names></name><name><surname>Ozgur</surname> <given-names>S</given-names></name><name><surname>Stoecklin</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genome-wide assessment of AU-rich elements by the AREScore algorithm</article-title><source>PLOS Genetics</source><volume>8</volume><elocation-id>e1002433</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002433</pub-id><pub-id pub-id-type="pmid">22242014</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudhakaran</surname> <given-names>IP</given-names></name><name><surname>Hillebrand</surname> <given-names>J</given-names></name><name><surname>Dervan</surname> <given-names>A</given-names></name><name><surname>Das</surname> <given-names>S</given-names></name><name><surname>Holohan</surname> <given-names>EE</given-names></name><name><surname>Hülsmeier</surname> <given-names>J</given-names></name><name><surname>Sarov</surname> <given-names>M</given-names></name><name><surname>Parker</surname> <given-names>R</given-names></name><name><surname>VijayRaghavan</surname> <given-names>K</given-names></name><name><surname>Ramaswami</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>FMRP and Ataxin-2 function together in long-term olfactory habituation and neuronal translational control</article-title><source>PNAS</source><volume>111</volume><fpage>E99</fpage><lpage>E108</lpage><pub-id pub-id-type="doi">10.1073/pnas.1309543111</pub-id><pub-id pub-id-type="pmid">24344294</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>G</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Rossi</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Sequence context outside the target region influences the effectiveness of miR-223 target sites in the RhoB 3′UTR</article-title><source>Nucleic Acids Research</source><volume>38</volume><fpage>239</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp870</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swisher</surname> <given-names>KD</given-names></name><name><surname>Parker</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Localization to, and effects of Pbp1, Pbp4, Lsm12, Dhh1, and Pab1 on stress granules in <italic>Saccharomyces cerevisiae</italic></article-title><source> PLOS ONE</source><volume>5</volume><elocation-id>e10006</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0010006</pub-id><pub-id pub-id-type="pmid">20368989</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trapnell</surname> <given-names>C</given-names></name><name><surname>Pachter</surname> <given-names>L</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>TopHat: discovering splice junctions with RNA-Seq</article-title><source>Bioinformatics</source><volume>25</volume><fpage>1105</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp120</pub-id><pub-id pub-id-type="pmid">19289445</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Loo</surname> <given-names>S</given-names></name><name><surname>Eich</surname> <given-names>F</given-names></name><name><surname>Nonis</surname> <given-names>D</given-names></name><name><surname>Auburger</surname> <given-names>G</given-names></name><name><surname>Nowock</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ataxin-2 associates with rough endoplasmic reticulum</article-title><source>Experimental Neurology</source><volume>215</volume><fpage>110</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2008.09.020</pub-id><pub-id pub-id-type="pmid">18973756</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Kouwenhove</surname> <given-names>M</given-names></name><name><surname>Kedde</surname> <given-names>M</given-names></name><name><surname>Agami</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MicroRNA regulation by RNA-binding proteins and its implications for Cancer</article-title><source>Nature Reviews Cancer</source><volume>11</volume><fpage>644</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1038/nrc3107</pub-id><pub-id pub-id-type="pmid">21822212</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Treeck</surname> <given-names>B</given-names></name><name><surname>Protter</surname> <given-names>DSW</given-names></name><name><surname>Matheny</surname> <given-names>T</given-names></name><name><surname>Khong</surname> <given-names>A</given-names></name><name><surname>Link</surname> <given-names>CD</given-names></name><name><surname>Parker</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>RNA self-assembly contributes to stress granule formation and defining the stress granule transcriptome</article-title><source>PNAS</source><volume>115</volume><fpage>2734</fpage><lpage>2739</lpage><pub-id pub-id-type="doi">10.1073/pnas.1800038115</pub-id><pub-id pub-id-type="pmid">29483269</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Treeck</surname> <given-names>B</given-names></name><name><surname>Parker</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Emerging roles for intermolecular RNA-RNA interactions in RNP assemblies</article-title><source>Cell</source><volume>174</volume><fpage>791</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.07.023</pub-id><pub-id pub-id-type="pmid">30096311</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasudevan</surname> <given-names>S</given-names></name><name><surname>Peltz</surname> <given-names>SW</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Regulated ARE-mediated mRNA decay in <italic>Saccharomyces cerevisiae</italic></article-title><source>Molecular Cell</source><volume>7</volume><fpage>1191</fpage><lpage>1200</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(01)00279-9</pub-id><pub-id pub-id-type="pmid">11430822</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wadia</surname> <given-names>NH</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Heredo familial spinocerebellar degeneration with slow eye movements; another variety of olivopontocerebellar degeneration</article-title><source>Neurology India</source><volume>25</volume><fpage>147</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">613260</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wadia</surname> <given-names>NH</given-names></name><name><surname>Swami</surname> <given-names>RK</given-names></name></person-group><year iso-8601-date="1971">1971</year><article-title>A new form of heredo-familial spinocerebellar degeneration with slow eye movements (nine families)</article-title><source>Brain</source><volume>94</volume><fpage>359</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1093/brain/94.2.359</pub-id><pub-id pub-id-type="pmid">5571047</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Yi</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>3'UTRs take a long shot in the brain</article-title><source>BioEssays</source><volume>36</volume><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1002/bies.201300100</pub-id><pub-id pub-id-type="pmid">24115048</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weidmann</surname> <given-names>CA</given-names></name><name><surname>Raynard</surname> <given-names>NA</given-names></name><name><surname>Blewett</surname> <given-names>NH</given-names></name><name><surname>Van Etten</surname> <given-names>J</given-names></name><name><surname>Goldstrohm</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The RNA binding domain of pumilio antagonizes poly-adenosine binding protein and accelerates deadenylation</article-title><source>RNA</source><volume>20</volume><fpage>1298</fpage><lpage>1319</lpage><pub-id pub-id-type="doi">10.1261/rna.046029.114</pub-id><pub-id pub-id-type="pmid">24942623</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>ggplot2: elegant graphics for data analysis by WICKHAM, H</article-title><source>Biometrics</source><volume>67</volume><fpage>678</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1111/j.1541-0420.2011.01616.x</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolozin</surname> <given-names>B</given-names></name><name><surname>Ivanov</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Stress granules and neurodegeneration</article-title><source>Nature Reviews Neuroscience</source><volume>20</volume><fpage>649</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1038/s41583-019-0222-5</pub-id><pub-id pub-id-type="pmid">31582840</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname> <given-names>S</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>LC</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Ding</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Yu</surname> <given-names>Y</given-names></name><name><surname>McKnight</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The LC domain of hnRNPA2 adopts similar conformations in hydrogel polymers, Liquid-like droplets, and nuclei</article-title><source>Cell</source><volume>163</volume><fpage>829</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.10.040</pub-id><pub-id pub-id-type="pmid">26544936</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Rahman</surname> <given-names>R</given-names></name><name><surname>Rosbash</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanistic implications of enhanced editing by a HyperTRIBE RNA-binding protein</article-title><source>RNA</source><volume>24</volume><fpage>173</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1261/rna.064691.117</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Y-S</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Litsios</surname> <given-names>A</given-names></name><name><surname>Sutter</surname> <given-names>BM</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Hsu</surname> <given-names>C-H</given-names></name><name><surname>Wood</surname> <given-names>NE</given-names></name><name><surname>Lemoff</surname> <given-names>A</given-names></name><name><surname>Mirzaei</surname> <given-names>H</given-names></name><name><surname>Heinemann</surname> <given-names>M</given-names></name><name><surname>Tu</surname> <given-names>BP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Yeast Ataxin-2 forms an intracellular condensate required for the inhibition of TORC1 signaling during respiratory growth</article-title><source>Cell</source><volume>177</volume><fpage>697</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.02.043</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoshi</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>Q</given-names></name><name><surname>Yamamoto</surname> <given-names>M</given-names></name><name><surname>Okada</surname> <given-names>H</given-names></name><name><surname>Suzuki</surname> <given-names>Y</given-names></name><name><surname>Kawahara</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Direct binding of Ataxin-2 to distinct elements in 3' UTRs promotes mRNA stability and protein expression</article-title><source>Molecular Cell</source><volume>55</volume><fpage>186</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.05.022</pub-id><pub-id pub-id-type="pmid">24954906</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Ling</surname> <given-names>J</given-names></name><name><surname>Yuan</surname> <given-names>C</given-names></name><name><surname>Dubruille</surname> <given-names>R</given-names></name><name><surname>Emery</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A role for <italic>Drosophila</italic> ATX2 in activation of PER translation and circadian behavior</article-title><source>Science</source><volume>340</volume><fpage>879</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1126/science.1234746</pub-id><pub-id pub-id-type="pmid">23687048</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.60326.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Black</surname><given-names>Douglas L</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Los Angeles</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Rosbash</surname><given-names>Michael</given-names> </name><role>Reviewer</role><aff><institution>Howard Hughes Medical Institute, Brandeis University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This study offers valuable insight into the Drosophila Ataxin2 protein, examining how it affects translational control and assembly of mRNP granules in the fly brain. Ataxin2 is of broad interest because human mutations in Atx2 cause particular neurodegenerative disorders. The identification of RNA interactions of Atx2 specifically in the RNP granules of neurons in the adult fly will be important for understanding Atx2 function and potentially its pathological roles.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Douglas Black as Reviewing Editor and Utpal Banerjee as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Michael Rosbash (Reviewer #1).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you revise the study.</p><p>The editors have judged that your manuscript is of interest, but as described below additional experiments and re-review will be required before it can be considered further. We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Summary:</p><p>Singh and colleagues examine the interactions of the Ataxin2 protein in <italic>Drosophila</italic>. Ataxin2 is a cytoplasmic RNA binding protein affecting translational control and mRNA stability that mediates assembly of mRNAs into stress granules and neuronal mRNP granules. It is a protein of broad current interest because human mutations in Atx2 can cause spinocerebellar ataxia type II (SCA2) and amyotrophic lateral sclerosis (AML). Both of these diseases seem to involve the aberrant aggregation of RNA binding proteins. In this study the authors examine the RNAs associated with Dm Atx2 specifically in the fly brain, using TRIBE. TRIBE involves fusing a protein of interest to the active domain of adenosine deaminase (ADAR). This fusion protein when expressed in cells will cause adenosine residues adjacent to sites of Atx2 binding to be converted to inosine which codes as guanosine. The presence of A to G transitions in the isolated RNA indicate adjacent binding of Atx2. Expressing their Atx2-ADAR fusion in fly brains with a temperature sensitive Gal4 system, they isolate mRNAs specifically modified by the Atx2 interaction in adult brains. This identified several hundred sites of modification indicating Atx2 interaction with 256 gene transcripts. They show that these transcripts are primarily modified in their 3' UTR sequences and the regions adjacent to these modifications are enriched in AU rich elements (AREs) known to cause mRNA instability. Knocking down Atx2 was found to reduce expression of target mRNA's, consistent with the protein stabilizing RNAs targeted for decay by the AREs. The authors then tested a series of deletions within the fusion protein to examine which domains of Atx2 affect its interaction with these target mRNAs. Surprisingly, they found that the structured domains of Atx2 including the LSM, which are thought to mediate its RNA interaction, had little effect on the identified RNA modifications. Instead removal of a c-terminal intrinsically disordered domain cIDR dramatically reduced the RNA targeting. IDR's are currently being widely studied for their ability mediate the aggregation of RNAs and proteins into intracellular condensates, of which stress granules and neuronal granules are two examples. The authors then test their Atx2 mutants for their intracellular aggregation by transfecting S2 cells with SNAP-tagged Atx2 genes. They find that the ectopic protein does form stress granule-like condensates in cells and this requires the presence of the cIDR. The presence of the LSM domain reduces the size of these condensates.</p><p>The reviewers agreed that this study is of substantial potential interest. The identification of RNA interactions of Atx2 that are specifically in the RNA granules of neurons in the adult fly, and different from earlier sets of interactions, is very exciting and will be important for understanding both Atx2 normal function, and potentially its pathological roles. However, all the reviewers found the study to be lacking essential validation, to be missing fundamental controls, and to require an unusually large number of smaller clarifications.</p><p>Essential revisions:</p><p>1) The loss of mRNAs upon depletion of Atx2 is not rigorously connected to the binding of Atx2 or to ARE's, and it is not necessarily due to increased RNA decay as proposed. In fact, the criteria for inclusion in Figure 3F are not clear, with some fold changes being very small. Do the magnitude of these changes correlate with the ARE score? The connection of Atx2 to these expression changes should be more carefully addressed with reporter constructs in S2 cells. Does Atx-2 expression lead to stabilization of particular target RNAs? Is this effect dependent on the AREs or other elements? Testing the Atx2 mutants, does stabilization or destabilization correlate with granule formation? If the effects on mRNA abundance are directly due to this cytoplasmic protein, then transcription rates should not change. This could be examined by measuring nascent (intron containing) RNA levels.</p><p>2) The authors should confirm that each of the proteins with domain deletions exhibit equal steady state expression by immunoblot. This is a standard and essential control as the loss of binding (or gain of more targets) could be due to lesser (or greater) expression of a domain-deleted protein compared to the wt. Similarly, the amount of Atx2 protein remaining after RNAi depletion should be determined by immunoblot. Just measuring the RNA level is not usually considered sufficient.</p><p>3) The model proposed in Figure 6 is consistent with their data, but there are other interpretations. One is that the fusion protein is not fully functional. In this regard, they need to show that the TRIBE fusion gene can rescue loss of the wildtype endogenous gene. Second, there remains the possibility that Atx2 has two modes of RNA interaction and that if it engages with RNA through the structured domains, it is in a configuration that does not allow interaction of the deaminase with the target. This would explain why they do not observe previously identified Atx2 interactions in this assay. This should be discussed.</p><p>4) It is not clear that the IDR is making a direct interaction with the ARE's. The referenced Biswas paper makes clear that spatial proximity a deaminase bound RNA with an unbound RNA can be sufficient to produce &quot;off target&quot; editing. It is possible that one of the known ARE binding proteins is recruiting the RNAs to the granule where they encounter Atx2. This does not negate the interest of the Atx2 interactions. It may be difficult to test this scenario experimentally, but it should be discussed as a possible, indeed likely, explanation for some of the data.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.60326.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The loss of mRNAs upon depletion of Atx2 is not rigorously connected to the binding of Atx2 or to ARE's, and it is not necessarily due to increased RNA decay as proposed. In fact, the criteria for inclusion in Figure 3F are not clear, with some fold changes being very small. Do the magnitude of these changes correlate with the ARE score? The connection of Atx2 to these expression changes should be more carefully addressed with reporter constructs in S2 cells. Does Atx-2 expression lead to stabilization of particular target RNAs? Is this effect dependent on the AREs or other elements? Testing the Atx2 mutants, does stabilization or destabilization correlate with granule formation? If the effects on mRNA abundance are directly due to this cytoplasmic protein, then transcription rates should not change. This could be examined by measuring nascent (intron containing) RNA levels.</p></disp-quote><p>We accept the criticism that the proposed role for Atx2 in stabilization of target RNAs via an ARE dependent mechanism could be more rigorously established. We have responded to this concern in two ways: 1A, by providing and highlighting additional lines of evidence in support of our proposal; and 1B, by acknowledging remaining ambiguities: e.g., that our proposal may not be applicable to a randomly selected individual mRNA.</p><p>A) Additional lines of evidence in support of Atx2-operating via AREs to stabilize mRNA.</p><p>i) The reviewers are correct that AREs scores for individual mRNAs shown in Figure 3F do not have sufficient predictive power. However, a global analysis (Figure 3E) supports a role for Atx2 in stabilizing (or at least increasing steady-state levels) of a significant subset of target mRNAs via an ARE dependent mechanism. This statistically significant, overall correlation between the ARE score of targets and their downregulation after Atx2 k/d is shown in Figure 3E. We have moved the Figure 3F to Figure 3—figure supplement 2 for anyone interested in effects on individual mRNAs.</p><p>ii) Our observations in adult fly brain are now supported by additional Atx2 TRIBE analyses we performed in S2 cells. In these cells too, Atx2 -ADAR edits are preferentially seen in AU rich sequences in the 3’UTRs of target mRNAs. As in adult brain, reduction of Atx2 levels using dsRNA decreases steady-state levels of about 49% of identified targets. Interestingly, induction of Atx2-ADAR (which also induces RNP granule formation) resulted in <italic>increased</italic> levels of 74% of the targets downregulated following Atx2 RNAi. These new observations, showing connections between Atx2 and AREs in different cell types, and bidirectional effects of reducing or increasing Atx2(-ADAR) levels (see response to point 3), are added to the revised manuscript as Figure 3—figure supplements 4, 5 and 6 and described in the revised text.</p><p>Note that the Atx2 TRIBE targets identified in S2 cells only marginally overlap with the brain targets, which is not surprising considering the mRNA targets from 2 different neuronal subtypes can also be very different (McMahon et al., 2016).</p><p>iii) A new analyses of our sequence reads provides further support for a role for Atx2 in regulating mRNA turnover. The changes in steady-state levels of target mRNAs we report could be due to changes either in mRNA stability or transcription. If transcriptional levels were altered, one might predict that Atx2 knockdown would result in altered nuclear-cytoplasmic ratios, reflected in intron-content of target mRNAs. We performed an intron analysis, which showed no significant change in Atx2 target mRNA levels between control and Atx2 RNAi. These new data, included as Figure 3—figure supplement 3 of the revised manuscript, provide some additional support for our proposal that downregulation of Atx2 targets following Atx2 knockdown occurs through a posttranscriptional mechanism, consistent with a role for Atx2 in modulating RNA stabilization.</p><p>iv) We have not performed the suggested analyses of individual mRNA reporters in S2 cells for the following reasons. First, we expect some mRNAs to be stabilized, some to be destabilized and some to be unchanged. This is in part from our analysis (previous Figure 3F, now Figure 3—figure supplement 2). But also from known properties of AU-Rich elements, which can be either stabilizing and destabilizing based on the nature of the associated RNP complex (Vasudevan and Peltz, 2001; Otsuka et al., 2019). Thus, the result will not reflect a general role for Atx2, but rather a specific effect on that UTR. We hesitate to select a few targets that would be most likely to fit one model alone. Second, some data on these lines already exists, MS2 tethering assays have already demonstrated that direct binding of Ataxin-2 to the 3’UTR can increase mRNA stability and protein expression in human (Yokoshi et al., Mol Cell, 2017 and Inagaki et al., 2020) as well as in <italic>Drosophila</italic> cells (Lim and Allada, 2013). In these cases Atx2 acts as to increase levels of its target mRNAs, Our published work (e.g. McCann et al., 2011 and Sudhakaran et al., 2014) shows that Ataxin-2 can act a translational repressor, e.g. for CaMKII mRNA and a selection of miRNA target genes.</p><p>B) We clarify our model and acknowledge remaining ambiguities: e.g., that our proposal may not be applicable to a randomly selected individual mRNA.</p><p>v) In the Abstract we add a small qualifier, now stating saying that Atx2 interactions with AU-rich elements “appear to” modulate stability.</p><p>vi) In the Results, we highlight that protein association with AREs can result in either stabilization or destabilization of the mRNA, thereby acknowledging that the effect of high ARE content in a UTR can be hard to interpret without direct experimentation.</p><p>vii) The Discussion also acknowledges and considers how the effect of Atx2 on stabilities of individual ARE-containing target mRNAs could vary.</p><disp-quote content-type="editor-comment"><p>2) The authors should confirm that each of the proteins with domain deletions exhibit equal steady state expression by immunoblot. This is a standard and essential control as the loss of binding (or gain of more targets) could be due to lesser (or greater) expression of a domain-deleted protein compared to the wt. Similarly, the amount of Atx2 protein remaining after RNAi depletion should be determined by immunoblot. Just measuring the RNA level is not usually considered sufficient.</p></disp-quote><p>To address the first point, we now include a Western blot (Figure 4—figure supplement 3C) which documents comparable levels of expression across experimental strains expressing different Atx2 domain deletions. These new data show that observed differences in TRIBE targets, particularly for the key lines expressing wild-type, Δ-Lsm and Δ c-IDR forms of Ataxin-2, cannot be accounted for by altered levels of transgene expression.</p><p>For the second point, we have also added a Figure 3—figure supplement 1 to show the Atx2 RNAi lines used in the study reduce the Atx2 protein levels when driven in wing discs using patched-Gal4. We have found this difficult to confirm this in Western blots of protein lysates from brains of flies expressing Atx2 RNAi. The difficulty is likely because Atx2 expression is driven by <italic>elav-gal4</italic>, which is variably expressed across neurons in the adult brain and not expressed in glial cells. This probably accounts also for the modest reduction in Atx2 mRNA levels observed in whole brain mRNA analysis. We have altered the Results to indicate this limitation.</p><p>However, do note that the additional analyses of the effects of Atx2 knockdown achieved by application of unrelated Atx2 dsRNA constructs on S2 cell TRIBE-targets not only provide data consistent with what we observe with Atx2-RNAi in fly brain but also, by showing the opposing effect of Atx2 overexpression, adds further support for our interpretation of the Atx2 RNAi observations.</p><disp-quote content-type="editor-comment"><p>3) The model proposed in Figure 6 is consistent with their data, but there are other interpretations. One is that the fusion protein is not fully functional. In this regard, they need to show that the TRIBE fusion gene can rescue loss of the wildtype endogenous gene. Second, there remains the possibility that Atx2 has two modes of RNA interaction and that if it engages with RNA through the structured domains, it is in a configuration that does not allow interaction of the deaminase with the target. This would explain why they do not observe previously identified Atx2 interactions in this assay. This should be discussed.</p></disp-quote><p>A) Regarding the full functionality of the Atx2-ADAR fusion protein.</p><p>The exact experiment suggested here is difficult to do. Neural overexpression of Atx2 via a UAS-Atx2 causes lethality and no one has yet succeeded in rescuing null ataxin-2 alleles using UAS-Atx2 transgenes, likely because a specific complex promoter is required. However, we offer other lines of evidence showing that C-terminal modifications of Atx2 do not significantly affect Atx2 functions. These observations substantially moderate our concern regarding this issue.</p><p>i) We have earlier shown that adding a large c-terminal tag (GFP) to Atx2 using genome engineering at the endogenous locus does not affect Atx2 activity, These Atx2-GFP flies are completely viable, as are similarly engineered flies carrying far more complex C-terminal modifications (-FRT-cIDR-dsRed-STOP FRT-GFP). Similarly, genomic transgenes (containing the native Atx2 promoter, exons, introns and 3’ regulatory sequences) encoding Atx2 carrying a C-terminal GFP tag completely rescue lethality of <italic>atx2</italic> null mutants (Bakthavachalu et al., 2018; Roselli, Bakthavachalu, Ramaswami, unpublished ). Thus, modifying or adding other tags onto the Atx2 C-terminus does not have significant consequences to the protein function.</p><p>ii) The addition of a c-terminal SNAP (or GFP) tag on Atx2 does not alter the protein’s native ability to form granules in S2 cells in a manner that is dependent on its cIDR. Atx2-ADAR constructs also behave similarly in S2 cells.</p><p>B) Regarding the suggestion that Atx2 may have two modes of RNA interaction</p><p>We completely agree that when Ataxin-2 engages with RNA through the Lsm domain, it may be in a configuration that does not allow interaction of the deaminase with its targets. This is the model we favour, but perhaps did not make as clear as we hoped. The point is implicitly acknowledged in the legend of Figure 6. We discuss this further in the Discussion. Moreover, we state in the text that RNA immunoprecipitation or other methodologies may be required identify additional Atx2 targets that are not identified by TRIBE.</p><disp-quote content-type="editor-comment"><p>4) It is not clear that the IDR is making a direct interaction with the ARE's. The referenced Biswas paper makes clear that spatial proximity a deaminase bound RNA with an unbound RNA can be sufficient to produce &quot;off target&quot; editing. It is possible that one of the known ARE binding proteins is recruiting the RNAs to the granule where they encounter Atx2. This does not negate the interest of the Atx2 interactions. It may be difficult to test this scenario experimentally, but it should be discussed as a possible, indeed likely, explanation for some of the data.</p></disp-quote><p>There are two separate issues implicit to this comment. We completely agree that the IDR may not directly contact the ARE and that Atx2 may be placed in proximity to the ARE by association with an independent ARE-binding protein. We now mention this in a revised legend to Figure 6. In one scenario, this indirect engagement with mRNA may occur in cis, i.e. the Atx2-deaminase fusion is brought specifically in contact with the ARE-binding protein and its associated mRNA. In this scenario the mRNA may still a be considered to be a bona fide Atx2 target, just brought to it by an indirect mechanism. In a second scenario, where proximity is achieved simply by concentration of Atx2 and ARE-containing mRNAs in granules, “off-target” editing is certainly possible. To minimize this class of off-target edits, which we expect to occur relatively randomly across the sequence of mRNAs in RNP granules, our data sets only report targets that were edited at the exact same genomic coordinate in independent replicate experiments. Doing so, we might have missed some real targets, but this should minimize mRNAs edited by random deaminase collisions between molecules concentrated in the same granule. We discuss some these issues and in the Discussion and hope that we cite the Biswas paper appropriately.</p></body></sub-article></article>